| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | CPLANE2 MYH7 ABCA3 ERCC6 ATP5PO ATP10B RAB3C ABCB1 EFTUD2 BLM RAB10 RAB33A DDX54 RAB5A RAB5B RAB6A RAB5C AGAP1 PMS1 NLRP1 CCT2 HELQ RAB6B RGS12 RAB36 ARHGAP5 DNAH12 CCT5 RAB21 SNRNP200 SMC1B | 3.95e-08 | 775 | 263 | 31 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | CPLANE2 MYH7 ABCA3 ERCC6 ATP5PO TRPM2 ATP10B RAB3C ABCB1 EFTUD2 BLM RAB10 RAB33A DDX54 RAB5A RAB5B RAB6A RAB5C AGAP1 PMS1 NLRP1 CCT2 HELQ RAB6B RGS12 RAB36 ARHGAP5 DNAH12 CCT5 RAB21 SNRNP200 SMC1B | 7.02e-08 | 839 | 263 | 32 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | CPLANE2 MYH7 ABCA3 ERCC6 ATP5PO TRPM2 ATP10B RAB3C ABCB1 EFTUD2 BLM RAB10 RAB33A DDX54 RAB5A RAB5B RAB6A RAB5C AGAP1 PMS1 NLRP1 CCT2 HELQ RAB6B RGS12 RAB36 ARHGAP5 DNAH12 CCT5 RAB21 SNRNP200 SMC1B | 7.22e-08 | 840 | 263 | 32 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | CPLANE2 MYH7 ABCA3 ERCC6 ATP5PO TRPM2 ATP10B RAB3C ABCB1 EFTUD2 BLM RAB10 RAB33A DDX54 RAB5A RAB5B RAB6A RAB5C AGAP1 PMS1 NLRP1 CCT2 HELQ RAB6B RGS12 RAB36 ARHGAP5 DNAH12 CCT5 RAB21 SNRNP200 SMC1B | 7.22e-08 | 840 | 263 | 32 | GO:0016818 |
| GeneOntologyMolecularFunction | actin filament binding | MYH7 MYO7A MYO7B ACTN4 CLASP2 ACTN1 ACTN3 SVIL TLN2 GAS7 SHTN1 ARPC5 TLN1 | 1.05e-05 | 227 | 263 | 13 | GO:0051015 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 ABCA3 ERCC6 ATP5PO CENPE MYO7A MYO7B ATP10B ABCB1 BLM DDX54 KIF11 PMS1 EP400 NLRP1 CCT2 HELQ DNAH1 DNAH12 CCT5 SNRNP200 SMC1B | 2.30e-05 | 614 | 263 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | GTPase activity | CPLANE2 RAB3C EFTUD2 RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C AGAP1 RAB6B RGS12 RAB36 ARHGAP5 RAB21 | 5.03e-05 | 341 | 263 | 15 | GO:0003924 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH7 CENPE MYO7A MYO7B INPPL1 ACTN4 CLASP2 RABGAP1 ACTN1 ACTN3 RAB3C RAB10 PTPN3 MTUS1 SVIL TRIM63 TLN2 DCLK2 UTRN RAB6A KIF11 TRIM46 CACNA1C SLC26A5 GAS7 SHTN1 RAB6B ARPC5 SPATC1 CCT5 TLN1 | 5.43e-05 | 1099 | 263 | 31 | GO:0008092 |
| GeneOntologyMolecularFunction | guanyl nucleotide binding | CPLANE2 RAB3C EFTUD2 RAB10 RAB33A CNGB1 RAB5A RAB5B RAB6A MOCS1 RAB5C AGAP1 PDE11A RAB6B RAB36 CNGB3 RAB21 | 7.82e-05 | 439 | 263 | 17 | GO:0019001 |
| GeneOntologyMolecularFunction | guanyl ribonucleotide binding | CPLANE2 RAB3C EFTUD2 RAB10 RAB33A CNGB1 RAB5A RAB5B RAB6A MOCS1 RAB5C AGAP1 PDE11A RAB6B RAB36 CNGB3 RAB21 | 7.82e-05 | 439 | 263 | 17 | GO:0032561 |
| GeneOntologyMolecularFunction | myosin V binding | 1.21e-04 | 20 | 263 | 4 | GO:0031489 | |
| GeneOntologyMolecularFunction | ethanolamine transmembrane transporter activity | 1.73e-04 | 2 | 263 | 2 | GO:0034228 | |
| GeneOntologyMolecularFunction | tryptophan 5-monooxygenase activity | 1.73e-04 | 2 | 263 | 2 | GO:0004510 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH7 ABCA3 ERCC6 ATP5PO ATP10B ABCB1 BLM DDX54 PMS1 NLRP1 CCT2 HELQ DNAH12 CCT5 SNRNP200 SMC1B | 2.65e-04 | 441 | 263 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | 2,4-dienoyl-CoA reductase (NADPH) activity | 5.14e-04 | 3 | 263 | 2 | GO:0008670 | |
| GeneOntologyMolecularFunction | vinculin binding | 5.86e-04 | 13 | 263 | 3 | GO:0017166 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 7.38e-04 | 14 | 263 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | GTP binding | CPLANE2 RAB3C EFTUD2 RAB10 RAB33A RAB5A RAB5B RAB6A MOCS1 RAB5C AGAP1 RAB6B RAB36 RAB21 | 8.39e-04 | 397 | 263 | 14 | GO:0005525 |
| GeneOntologyMolecularFunction | intracellularly ligand-gated monoatomic ion channel activity | 8.91e-04 | 33 | 263 | 4 | GO:0005217 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 9.67e-04 | 118 | 263 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | G protein activity | 1.07e-03 | 59 | 263 | 5 | GO:0003925 | |
| GeneOntologyMolecularFunction | cGMP binding | 1.11e-03 | 16 | 263 | 3 | GO:0030553 | |
| GeneOntologyMolecularFunction | flippase activity | 1.34e-03 | 17 | 263 | 3 | GO:0140327 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair via homologous recombination | 1.87e-05 | 44 | 262 | 6 | GO:1905168 | |
| GeneOntologyBiologicalProcess | protein complex oligomerization | ABCA3 RIPOR2 ACOT13 TRPM2 ITPR1 BLM KCNC3 UGDH PKM SYT1 ALDH1A3 HSD17B8 CPSF6 NLRP1 | 2.78e-05 | 296 | 262 | 14 | GO:0051259 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH7 MYO7A MYO7B INPPL1 TRPM2 INSRR ACTN4 CLASP2 ACTN1 ACTN3 PGM5 FAT1 KCNC3 SVIL TLN2 NPHP1 MAGEL2 CASP4 GAS7 CLDN3 SHTN1 ARPC5 PPARGC1B SH3PXD2B TLN1 | 3.61e-05 | 803 | 262 | 25 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH7 MYO7A MYO7B INPPL1 TRPM2 INSRR ACTN4 CLASP2 ACTN1 ACTN3 PGM5 FAT1 KCNC3 SVIL TLN2 NPHP1 CACNA1C MAGEL2 DSP CASP4 GAS7 CLDN3 SHTN1 ARPC5 PPARGC1B SH3PXD2B TLN1 | 4.15e-05 | 912 | 262 | 27 | GO:0030029 |
| GeneOntologyCellularComponent | secretory granule membrane | ABCA3 TRPM2 ACTN1 ITPR1 RAB10 AP2A2 SURF4 SYT1 RAB5A RAB5B RAB6A RAB5C DSP UBR4 SLC44A2 | 2.07e-05 | 329 | 264 | 15 | GO:0030667 |
| GeneOntologyCellularComponent | pseudopodium | 6.62e-05 | 18 | 264 | 4 | GO:0031143 | |
| GeneOntologyCellularComponent | Z disc | 1.32e-04 | 151 | 264 | 9 | GO:0030018 | |
| GeneOntologyCellularComponent | I band | 2.69e-04 | 166 | 264 | 9 | GO:0031674 | |
| GeneOntologyCellularComponent | secretory granule | ABCA3 CEL TRPM2 ACTN4 ACTN1 F5 ITPR1 RAB10 STXBP3 AP2A1 AP2A2 SURF4 PKM SYT1 RAB5A RAB5B RAB6A RAB5C TCN1 DSP UBR4 SLC44A2 FNDC3A CCT2 ARPC5 LACRT | 5.07e-04 | 1014 | 264 | 26 | GO:0030141 |
| GeneOntologyCellularComponent | fascia adherens | 5.19e-04 | 13 | 264 | 3 | GO:0005916 | |
| GeneOntologyCellularComponent | perikaryon | CNTNAP3B TRPM2 CNTNAP3 KCNC3 PDE11A CACNA1C GRIK3 SHTN1 CNTNAP2 WDFY3 | 5.66e-04 | 223 | 264 | 10 | GO:0043204 |
| Domain | RAB | RAB3C RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C AGAP1 RAB6B RAB36 RAB21 | 4.72e-09 | 73 | 258 | 11 | PS51419 |
| Domain | Ras | CPLANE2 RAB3C RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C AGAP1 RAB6B RAB36 ARHGAP5 RAB21 | 5.28e-08 | 136 | 258 | 13 | PF00071 |
| Domain | Small_GTPase | CPLANE2 RAB3C RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C AGAP1 RAB6B RAB36 ARHGAP5 RAB21 | 3.57e-07 | 160 | 258 | 13 | IPR001806 |
| Domain | Small_GTP-bd_dom | CPLANE2 RAB3C EFTUD2 RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C AGAP1 RAB6B RAB36 RAB21 | 5.84e-07 | 167 | 258 | 13 | IPR005225 |
| Domain | P-loop_NTPase | CPLANE2 MYH7 ABCA3 ERCC6 CENPE MYO7A MYO7B RAB3C ABCB1 EFTUD2 BLM RAB10 RAB33A DDX54 RAB5A RAB5B RAB6A RAB5C KIF11 AGAP1 EP400 NLRP1 HELQ RAB6B DNAH1 RAB36 ARHGAP5 DNAH12 RAB21 SNRNP200 SMC1B | 7.84e-07 | 848 | 258 | 31 | IPR027417 |
| Domain | - | CPLANE2 ABCA3 ERCC6 MYO7A MYO7B RAB3C ABCB1 EFTUD2 BLM RAB10 RAB33A DDX54 RAB5A RAB5B RAB6A RAB5C AGAP1 EP400 NLRP1 HELQ RAB6B DNAH1 RAB36 ARHGAP5 DNAH12 RAB21 SNRNP200 SMC1B | 1.68e-06 | 746 | 258 | 28 | 3.40.50.300 |
| Domain | Spectrin_repeat | 2.39e-06 | 29 | 258 | 6 | IPR002017 | |
| Domain | SPEC | 4.39e-06 | 32 | 258 | 6 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 4.39e-06 | 32 | 258 | 6 | IPR018159 | |
| Domain | ARM-type_fold | USP34 RIPOR2 CLASP2 USP9Y TRRAP ITPR1 AP2A1 AP2A2 ATXN10 HEATR5B UBQLN2 BZW2 PKP4 UBR4 NOC3L NUP188 WDFY3 | 5.27e-06 | 339 | 258 | 17 | IPR016024 |
| Domain | Spectrin | 1.33e-05 | 23 | 258 | 5 | PF00435 | |
| Domain | - | PECR LDHAL6A ME2 DECR1 GFOD1 UGDH SDR16C5 HSD17B8 ISYNA1 TP53I3 H6PD | 2.39e-05 | 169 | 258 | 11 | 3.40.50.720 |
| Domain | PolyA | 2.55e-05 | 5 | 258 | 3 | SM00517 | |
| Domain | PABP | 2.55e-05 | 5 | 258 | 3 | PF00658 | |
| Domain | PABC | 2.55e-05 | 5 | 258 | 3 | PS51309 | |
| Domain | - | 2.55e-05 | 5 | 258 | 3 | 1.10.1900.10 | |
| Domain | PABP_1234 | 2.55e-05 | 5 | 258 | 3 | IPR006515 | |
| Domain | PABP_HYD | 2.55e-05 | 5 | 258 | 3 | IPR002004 | |
| Domain | NAD(P)-bd_dom | PECR LDHAL6A ME2 DECR1 GFOD1 UGDH SDR16C5 HSD17B8 ISYNA1 TP53I3 H6PD | 2.96e-05 | 173 | 258 | 11 | IPR016040 |
| Domain | RBD | 5.05e-05 | 6 | 258 | 3 | PF02196 | |
| Domain | EFhand_Ca_insen | 5.05e-05 | 6 | 258 | 3 | PF08726 | |
| Domain | EF-hand_Ca_insen | 5.05e-05 | 6 | 258 | 3 | IPR014837 | |
| Domain | FERM_central | 5.57e-05 | 49 | 258 | 6 | IPR019748 | |
| Domain | FERM_domain | 5.57e-05 | 49 | 258 | 6 | IPR000299 | |
| Domain | FERM_1 | 6.26e-05 | 50 | 258 | 6 | PS00660 | |
| Domain | FERM_2 | 6.26e-05 | 50 | 258 | 6 | PS00661 | |
| Domain | FERM_3 | 6.26e-05 | 50 | 258 | 6 | PS50057 | |
| Domain | Band_41_domain | 6.26e-05 | 50 | 258 | 6 | IPR019749 | |
| Domain | B41 | 6.26e-05 | 50 | 258 | 6 | SM00295 | |
| Domain | RBD | 8.75e-05 | 7 | 258 | 3 | SM00455 | |
| Domain | RBD_dom | 8.75e-05 | 7 | 258 | 3 | IPR003116 | |
| Domain | RBD | 8.75e-05 | 7 | 258 | 3 | PS50898 | |
| Domain | FA58C_3 | 1.77e-04 | 21 | 258 | 4 | PS50022 | |
| Domain | FA58C | 1.77e-04 | 21 | 258 | 4 | SM00231 | |
| Domain | FA58C_1 | 1.77e-04 | 21 | 258 | 4 | PS01285 | |
| Domain | FA58C_2 | 1.77e-04 | 21 | 258 | 4 | PS01286 | |
| Domain | - | 1.90e-04 | 2 | 258 | 2 | 1.20.1420.10 | |
| Domain | VBS | 1.90e-04 | 2 | 258 | 2 | PF08913 | |
| Domain | Clathrin_a-adaptin_app_Ig-like | 1.90e-04 | 2 | 258 | 2 | IPR013038 | |
| Domain | Talin_cent | 1.90e-04 | 2 | 258 | 2 | IPR015224 | |
| Domain | Talin_middle | 1.90e-04 | 2 | 258 | 2 | PF09141 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 1.90e-04 | 2 | 258 | 2 | IPR003164 | |
| Domain | - | 1.90e-04 | 2 | 258 | 2 | 2.60.40.1030 | |
| Domain | Vinculin-bd_dom | 1.90e-04 | 2 | 258 | 2 | IPR015009 | |
| Domain | AP2_complex_asu | 1.90e-04 | 2 | 258 | 2 | IPR017104 | |
| Domain | Alpha_adaptin_C | 1.90e-04 | 2 | 258 | 2 | PF02296 | |
| Domain | Trp_5_mOase | 1.90e-04 | 2 | 258 | 2 | IPR005963 | |
| Domain | Ubiquitin-rel_dom | 2.48e-04 | 184 | 258 | 10 | IPR029071 | |
| Domain | ACTININ_2 | 2.56e-04 | 23 | 258 | 4 | PS00020 | |
| Domain | ACTININ_1 | 2.56e-04 | 23 | 258 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.56e-04 | 23 | 258 | 4 | IPR001589 | |
| Domain | F5_F8_type_C | 3.04e-04 | 24 | 258 | 4 | PF00754 | |
| Domain | FA58C | 3.04e-04 | 24 | 258 | 4 | IPR000421 | |
| Domain | ARM-like | RIPOR2 CLASP2 USP9Y TRRAP AP2A1 AP2A2 ATXN10 HEATR5B RANGAP1 PKP4 NOC3L WDFY3 | 3.94e-04 | 270 | 258 | 12 | IPR011989 |
| Domain | CASPASE_HIS | 3.96e-04 | 11 | 258 | 3 | PS01121 | |
| Domain | FERM_M | 4.18e-04 | 46 | 258 | 5 | PF00373 | |
| Domain | Caspase_his_AS | 5.23e-04 | 12 | 258 | 3 | IPR016129 | |
| Domain | CASPASE_CYS | 5.23e-04 | 12 | 258 | 3 | PS01122 | |
| Domain | Pept_C14_p10 | 5.23e-04 | 12 | 258 | 3 | IPR002138 | |
| Domain | Caspase_cys_AS | 5.23e-04 | 12 | 258 | 3 | IPR033139 | |
| Domain | CASPASE_P10 | 5.23e-04 | 12 | 258 | 3 | PS50207 | |
| Domain | - | 5.62e-04 | 49 | 258 | 5 | 1.20.80.10 | |
| Domain | Ribosomal_S4e_central_region | 5.65e-04 | 3 | 258 | 2 | IPR013845 | |
| Domain | Ribosomal_S4e_N | 5.65e-04 | 3 | 258 | 2 | IPR013843 | |
| Domain | 40S_S4_C | 5.65e-04 | 3 | 258 | 2 | PF16121 | |
| Domain | Ribosomal_S4e_N_CS | 5.65e-04 | 3 | 258 | 2 | IPR018199 | |
| Domain | Ribosomal_S4e | 5.65e-04 | 3 | 258 | 2 | IPR000876 | |
| Domain | RIBOSOMAL_S4E | 5.65e-04 | 3 | 258 | 2 | PS00528 | |
| Domain | Ribosomal_S4e_central | 5.65e-04 | 3 | 258 | 2 | PD002667 | |
| Domain | ACT_dom | 5.65e-04 | 3 | 258 | 2 | IPR002912 | |
| Domain | ACT | 5.65e-04 | 3 | 258 | 2 | PS51671 | |
| Domain | ACT | 5.65e-04 | 3 | 258 | 2 | PF01842 | |
| Domain | Talin-1 | 5.65e-04 | 3 | 258 | 2 | IPR015710 | |
| Domain | 40S_S4_C | 5.65e-04 | 3 | 258 | 2 | IPR032277 | |
| Domain | RS4NT | 5.65e-04 | 3 | 258 | 2 | PF08071 | |
| Domain | Ribosomal_S4e | 5.65e-04 | 3 | 258 | 2 | PF00900 | |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 6.17e-04 | 50 | 258 | 5 | IPR014352 | |
| Domain | - | 6.29e-04 | 207 | 258 | 10 | 1.25.40.10 | |
| Domain | CASc | 6.73e-04 | 13 | 258 | 3 | SM00115 | |
| Domain | Pept_C14A | 6.73e-04 | 13 | 258 | 3 | IPR015917 | |
| Domain | - | 8.47e-04 | 14 | 258 | 3 | 3.40.50.1460 | |
| Domain | Pept_C14_p20 | 8.47e-04 | 14 | 258 | 3 | IPR001309 | |
| Domain | Caspase-like_dom | 8.47e-04 | 14 | 258 | 3 | IPR029030 | |
| Domain | CASPASE_P20 | 8.47e-04 | 14 | 258 | 3 | PS50208 | |
| Domain | FERM_N | 1.06e-03 | 33 | 258 | 4 | IPR018979 | |
| Domain | FERM_N | 1.06e-03 | 33 | 258 | 4 | PF09379 | |
| Domain | FERM_f0 | 1.12e-03 | 4 | 258 | 2 | PF16511 | |
| Domain | ArAA_hydroxylase_Fe/CU_BS | 1.12e-03 | 4 | 258 | 2 | IPR018301 | |
| Domain | BH4_AAA_HYDROXYL_2 | 1.12e-03 | 4 | 258 | 2 | PS51410 | |
| Domain | ILWEQ | 1.12e-03 | 4 | 258 | 2 | PD011820 | |
| Domain | I_LWEQ | 1.12e-03 | 4 | 258 | 2 | PF01608 | |
| Domain | I_LWEQ | 1.12e-03 | 4 | 258 | 2 | PS50945 | |
| Domain | Biopterin_H | 1.12e-03 | 4 | 258 | 2 | PF00351 | |
| Domain | FERM_f0 | 1.12e-03 | 4 | 258 | 2 | IPR032425 | |
| Domain | - | 1.12e-03 | 4 | 258 | 2 | 3.30.310.30 | |
| Domain | ILWEQ_dom | 1.12e-03 | 4 | 258 | 2 | IPR002558 | |
| Domain | ILWEQ | 1.12e-03 | 4 | 258 | 2 | SM00307 | |
| Domain | - | 1.12e-03 | 4 | 258 | 2 | 1.10.800.10 | |
| Domain | ArAA_hydroxylase | 1.12e-03 | 4 | 258 | 2 | IPR001273 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 1.12e-03 | 4 | 258 | 2 | IPR015873 | |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | RAB3C RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C RAB6B RAB36 RAB21 | 3.98e-08 | 65 | 211 | 10 | M27771 |
| Pathway | REACTOME_RAB_GERANYLGERANYLATION | RAB3C RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C RAB6B RAB36 RAB21 | 3.98e-08 | 65 | 211 | 10 | MM15511 |
| Pathway | REACTOME_TBC_RABGAPS | 3.65e-06 | 44 | 211 | 7 | M27748 | |
| Pathway | WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS | 5.24e-06 | 18 | 211 | 5 | M39737 | |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | CENPE RABGAP1 COPS2 F5 RAB10 RAB33A STXBP3 AP2A1 AP2A2 COG1 SURF4 AP1S2 SYT1 RAB5A RAB5B RAB6A RAB5C KIF11 UBQLN2 RAB6B ARPC5 RAB36 PRKAG1 RAB21 | 2.50e-05 | 630 | 211 | 24 | M11480 |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 6.94e-05 | 118 | 211 | 9 | MM15589 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | CENPE RABGAP1 COPS2 F5 RAB10 RAB33A STXBP3 AP2A1 AP2A2 COG1 SURF4 AP1S2 SYT1 RAB5A RAB5B RAB6A RAB5C KIF11 STAB2 UBQLN2 RAB6B ARPC5 RAB36 PRKAG1 RAB21 | 8.56e-05 | 725 | 211 | 25 | M27507 |
| Pathway | REACTOME_RAB_REGULATION_OF_TRAFFICKING | 9.00e-05 | 122 | 211 | 9 | M27872 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | CENPE RABGAP1 COPS2 F5 RAB10 RAB33A AP2A1 AP2A2 COG1 SURF4 AP1S2 SYT1 RAB5A RAB5B RAB6A RAB5C KIF11 STAB2 UBQLN2 RAB6B ARPC5 RAB36 RAB21 | 1.02e-04 | 645 | 211 | 23 | MM15232 |
| Pathway | BIOCARTA_CHEMICAL_PATHWAY | 1.27e-04 | 18 | 211 | 4 | MM1350 | |
| Pathway | BIOCARTA_CHEMICAL_PATHWAY | 1.27e-04 | 18 | 211 | 4 | M3873 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION | 1.75e-04 | 8 | 211 | 3 | M47778 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 2.85e-04 | 142 | 211 | 9 | MM15499 | |
| Pathway | BIOCARTA_CASPASE_PATHWAY | 2.89e-04 | 22 | 211 | 4 | M17902 | |
| Pathway | REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS | 3.33e-04 | 145 | 211 | 9 | M27753 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UTP6 ERCC6 ACTN4 ACTN1 MCCC1 TRRAP EFTUD2 BLM DECR1 PARP1 AP2A1 AP2A2 UGDH DDX54 PKM POLR1B UTRN TARS1 KIF11 RBM15 RANGAP1 EP400 DSP PKP4 UBR4 NOC3L NEK7 ELP1 CCT2 SRBD1 PABPC1 AARSD1 CCT5 TLN1 NFXL1 WDR82 PRMT3 TANC1 WDFY3 EIF2AK2 SNRNP200 FTSJ3 | 8.92e-15 | 1353 | 264 | 42 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | UTP6 ATP5PO PABPC4 ACTN4 ACTN1 TRRAP F5 ABCB1 EFTUD2 RAB10 PARP1 AP2A1 SURF4 SVIL DDX54 PKM ATXN10 HEATR5B UTRN RAB5B TARS1 RAB5C RBM15 RANGAP1 EP400 DSP CPSF6 ELP1 CCT2 PABPC1 CCT5 TLN1 NUP188 RAB21 SNRNP200 FTSJ3 | 2.30e-14 | 1024 | 264 | 36 | 24711643 |
| Pubmed | ATP5PO TRIO MYO7A RPS4Y1 PABPC4 ACTN4 CLASP2 ACTN1 ALDH1L1 ACTN3 SUCLA2 RAB10 PARP1 AP2A1 AP2A2 SVIL SCAPER UGP2 PKM SYT1 TLN2 DCLK2 UTRN TARS1 RAB5C TRIM46 RPS4Y2 RAF1 DSP PKP4 ELP1 CCT2 PABPC1 ARPC5 ARHGAP5 SLC44A1 CCT5 PABPC3 TLN1 TANC1 SNRNP200 DCLK1 | 5.87e-14 | 1431 | 264 | 42 | 37142655 | |
| Pubmed | ATP5PO HDAC4 MYO7A RPS4Y1 ACOT13 PABPC4 ACTN4 SUCLA2 EFTUD2 RAB10 PARP1 AP2A1 SURF4 UGDH UGP2 PKM RAB5B RAB6A RAB5C DSP NOC3L CCT2 PABPC1 ZFPM2 MYOF CCT5 TLN1 RAB21 EIF2AK2 DCLK1 FTSJ3 | 1.49e-13 | 803 | 264 | 31 | 36517590 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | UTP6 ATP5PO TRIO ACOT13 PABPC4 ACTN4 CLASP2 SUCLA2 ME2 EFTUD2 PARP1 STXBP3 AP2A1 AP2A2 MOGS SURF4 DDX54 PKM TLN2 ATXN10 TDRD6 TARS1 KIF11 RBM15 RANGAP1 DSP CPSF6 UBR4 NOC3L ELP1 CCT2 PABPC1 CCT5 TLN1 PRMT3 NUP188 EIF2AK2 SNRNP200 FTSJ3 | 4.39e-12 | 1425 | 264 | 39 | 30948266 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACTN4 ACTN1 ALDH1L1 MCCC1 EFTUD2 RAB10 PARP1 STXBP3 AP2A1 AP2A2 MOGS PKM UTRN RAB5A RAB5B RAB6A TARS1 RAB5C DSP CPSF6 UBR4 CCT2 PABPC1 DNAH1 MYOF CCT5 TLN1 SMS SNRNP200 | 5.48e-12 | 807 | 264 | 29 | 30575818 |
| Pubmed | USP34 MYH7 RIPOR2 UBQLN4 ACTN1 SUCLA2 RAB10 COG1 SURF4 DISP3 TRIM46 UBQLN2 DSP UBR4 RGS12 LIPE CCT5 TLN1 CDH4 | 7.64e-12 | 322 | 264 | 19 | 26514267 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH7 MAGEB2 HDAC4 PABPC4 CLASP2 COPS2 TRRAP EFTUD2 JAK1 RAB10 PTPN3 SURF4 UGP2 ATXN10 RAB5A TARS1 RAB5C RAF1 RANGAP1 HTR1B DSP BZW2 CPSF6 MPDU1 UBR4 NEK7 CASP4 PABPC1 ARPC5 ARAF LIG4 NUP188 DEDD EIF2AK2 SNRNP200 FTSJ3 | 1.63e-11 | 1284 | 264 | 36 | 17353931 |
| Pubmed | PABPC4 EFTUD2 BLM RAB10 PARP1 AP2A1 AP2A2 POLR1B RAB6A RAB5C RBM15 DSP SRBD1 RAB6B PABPC1 MYOF WDHD1 WDR82 SNRNP200 | 1.96e-11 | 340 | 264 | 19 | 24332808 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | ACTN4 EFTUD2 JAK1 PARP1 AP2A1 AP2A2 UGDH DDX54 PKM UTRN ATG2B CCT2 PABPC1 MYOF EIF2AK2 SNRNP200 FTSJ3 | 3.20e-11 | 268 | 264 | 17 | 33024031 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | UTP6 ATP5PO NT5C3A UBQLN4 RAB10 STXBP3 AP2A1 MOGS COG1 SURF4 TTC13 ATXN10 HEATR5B MTCH1 RAB6A TARS1 KIF11 RANGAP1 UBQLN2 BZW2 UBR4 NOC3L CASP3 ELP1 FNDC3A LMBR1L TLN1 NFXL1 NUP188 SLC33A1 | 4.49e-11 | 942 | 264 | 30 | 31073040 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYH7 PABPC4 ACTN4 CLASP2 ACTN1 COPS2 EFTUD2 RAB10 PARP1 AP2A1 AP2A2 SVIL UGP2 PKM ATXN10 TARS1 RAB5C KIF11 RAF1 RANGAP1 DSP CPSF6 UBR4 CCT2 SHTN1 PABPC1 ARPC5 CCT5 TLN1 RAB21 EIF2AK2 SNRNP200 FTSJ3 | 6.67e-11 | 1149 | 264 | 33 | 35446349 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | ATP5PO ACTN4 RABGAP1 ACTN1 MCCC1 SUCLA2 COPS2 ME2 EFTUD2 RAB10 BPNT1 PARP1 AP2A1 MOGS MTUS1 UGP2 PKM ATXN10 UTRN RAB5B KIF11 RANGAP1 ZBTB33 DSP CPSF6 UBR4 NOC3L CCT2 RAB6B PABPC1 AARSD1 MYOF SH3PXD2B CCT5 TLN1 PRKAG1 | 9.29e-11 | 1367 | 264 | 36 | 32687490 |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP5PO RPS4Y1 ACTN1 MCCC1 SUCLA2 TRRAP RAB3C ITPR1 RAB10 AP2A1 AP2A2 PKM SYT1 ATXN10 TDRD6 RAB6A RPS4Y2 STAB2 CCT2 RAB6B PABPC1 CCT5 PABPC3 DCLK1 | 9.45e-11 | 621 | 264 | 24 | 22794259 |
| Pubmed | PECR ACOT13 PABPC4 TRPM2 CLASP2 ACTN3 SUCLA2 DECR1 RAB10 PARP1 AP2A1 AP2A2 MOGS SVIL UGDH PKM ATXN10 RAB5A RAB5B RAB6A RAB5C RAF1 RBM15 EP400 DSP CPSF6 MPDU1 ELP1 PABPC1 ARHGAP5 CCT5 TLN1 WDR82 RAB21 EIF2AK2 FTSJ3 | 1.01e-10 | 1371 | 264 | 36 | 36244648 | |
| Pubmed | RAB3C RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C RAB6B RAB36 RAB21 | 1.90e-10 | 72 | 264 | 10 | 16923123 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | ATP5PO RPS4Y1 PABPC4 ACTN1 MCCC1 EFTUD2 PARP1 AP2A1 MOGS DDX54 PKM RPS4Y2 NOC3L PABPC3 SNRNP200 FTSJ3 | 3.74e-10 | 272 | 264 | 16 | 25315684 |
| Pubmed | Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity. | ATP5PO RPS4Y1 ACTN4 SUCLA2 AP2A1 AP2A2 PKM RAB5A RAB5C RPS4Y2 CPSF6 PABPC1 PABPC3 | 5.31e-10 | 166 | 264 | 13 | 27160897 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | UTP6 RPS4Y1 PABPC4 MCCC1 SUCLA2 EFTUD2 DECR1 RAB10 PARP1 AP2A1 AP2A2 SURF4 DDX54 PKM POLR1B RAB5A RAB5C RBM15 EP400 CPSF6 MPDU1 UBR4 NOC3L CCT2 RAB6B PABPC1 CCT5 PRKAG1 WDR82 PRMT3 RAB21 EIF2AK2 SNRNP200 FTSJ3 | 5.55e-10 | 1318 | 264 | 34 | 30463901 |
| Pubmed | 8.97e-10 | 61 | 264 | 9 | 12578829 | ||
| Pubmed | ATP5PO ACOT13 INPPL1 PABPC4 ACTN4 EFTUD2 DECR1 RAB10 PARP1 STXBP3 AP2A1 AP2A2 PKM TARS1 RAB5C BZW2 CPSF6 UBR4 CCT2 PABPC1 CCT5 TLN1 NUP188 SNRNP200 | 1.26e-09 | 707 | 264 | 24 | 19738201 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | UTP6 ACOT13 TRRAP JAK1 UGDH DDX54 RANGAP1 EP400 CPSF6 UBR4 NOC3L SRBD1 KMT2D WDHD1 WDR82 NUP188 EIF2AK2 | 1.32e-09 | 341 | 264 | 17 | 32971831 |
| Pubmed | UTP6 USP34 PABPC4 ACTN4 ACTN1 TRRAP ME2 BLM DDX54 UTRN RBM15 RANGAP1 DSP UBR4 NOC3L ELP1 CCT2 PABPC1 CCT5 TLN1 NUP188 SNRNP200 FTSJ3 | 1.41e-09 | 653 | 264 | 23 | 22586326 | |
| Pubmed | MYH7 ATP5PO RPS4Y1 PABPC4 ATP10B ACTN4 ACTN1 ACTN3 RAB3C ABCB1 RAB10 PARP1 AP2A1 AP2A2 COG1 UGP2 PKM KIF11 RPS4Y2 CACNA1C RANGAP1 DSP UBR4 NOC3L SLC44A2 CCT2 SRBD1 PABPC1 ARPC5 SPATC1 LIG4 PABPC3 NFXL1 IFT122 RAB21 | 1.49e-09 | 1442 | 264 | 35 | 35575683 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | PECR ACTN4 TRRAP RAB10 PARP1 AP2A2 PKM CPSF6 UBR4 CCT2 PABPC1 ARPC5 MYOF SH3PXD2B PABPC3 TLN1 SNRNP200 | 1.50e-09 | 344 | 264 | 17 | 30333137 |
| Pubmed | TRIO ACTN4 CLASP2 ITPR1 BLM RAB10 PARP1 PTPN3 STXBP3 MTUS1 SVIL DDX54 ATXN10 UTRN PMS1 RBM15 RANGAP1 DSP BZW2 PKP4 NOC3L ELP1 CCT2 ARHGAP5 KMT2D CCT5 WDR82 TANC1 FTSJ3 | 2.47e-09 | 1049 | 264 | 29 | 27880917 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | UTP6 ERCC6 PABPC4 ACTN4 ACTN1 F5 EFTUD2 DECR1 PARP1 PTPN3 AP2A1 MOGS SVIL DDX54 PKM POLR1B TARS1 RAB5C KIF11 RBM15 DSP CPSF6 PKP4 NOC3L CCT2 SRBD1 PABPC1 MYOF CCT5 EIF2AK2 SNRNP200 FTSJ3 | 2.57e-09 | 1257 | 264 | 32 | 36526897 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HDAC4 TRIO INPPL1 CLASP2 MCCC1 PTPN3 MTUS1 SVIL DCLK2 UTRN KIF11 ARAP2 RAF1 RBM15 DSP SHTN1 PABPC1 ARAF RGS12 SH3PXD2B SLF2 TET1 TANC1 RAB21 DCLK1 EDRF1 | 2.89e-09 | 861 | 264 | 26 | 36931259 |
| Pubmed | MYH7 BPIFB1 TRRAP ITPR1 PARP1 COG1 UGDH TMCO3 RAB6A RAB5C PMS1 RBM15 EP400 DSP CPSF6 NEK7 FNDC3A MUC13 ARAF MYOF CCT5 TRIM47 SNRNP200 SLC33A1 | 4.42e-09 | 754 | 264 | 24 | 35906200 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | UTP6 ATP5PO SUCLA2 COPS2 TRRAP AP2A1 PKM AP1S2 POLR1B KIF11 RANGAP1 UBR4 CASP3 ELP1 FNDC3A WDHD1 WDR82 SMS PRMT3 NUP188 RAB21 EIF2AK2 SNRNP200 | 5.80e-09 | 704 | 264 | 23 | 29955894 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | USP34 ATP5PO RPS4Y1 ACTN4 MCCC1 SUCLA2 ME2 ITPR1 EFTUD2 DECR1 RAB10 FAT1 MOGS SURF4 UGDH PKM RAB5A RAB5B RAB6A MOCS1 RAB5C RPS4Y2 DSP CPSF6 ELP1 CCT2 H6PD PABPC1 HPDL PABPC3 TLN1 TMX4 RAB21 SNRNP200 | 6.28e-09 | 1451 | 264 | 34 | 30550785 |
| Pubmed | RABGAP1 ACTN1 RAB10 AP2A2 PKM ATXN10 RAF1 DSP BZW2 UBR4 CCT2 DDIAS CCT5 PRKAG1 WDR82 | 6.99e-09 | 288 | 264 | 15 | 23383273 | |
| Pubmed | USP34 PABPC4 CLASP2 MCCC1 RAB3C EFTUD2 BLM PTPN3 FAT1 UGDH PKM TARS1 ARAP2 AGAP1 ZBTB33 EP400 CPSF6 NOC3L CCT2 ANKRD50 LIPE CCT5 RAB21 SNRNP200 | 7.87e-09 | 777 | 264 | 24 | 35844135 | |
| Pubmed | ATP5PO INPPL1 PABPC4 ACTN4 EFTUD2 DECR1 RAB10 PARP1 AP2A1 PKM TARS1 RAB5C UBR4 CCT2 PABPC1 CCT5 TLN1 NUP188 SNRNP200 | 8.95e-09 | 491 | 264 | 19 | 22623428 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | PKM KIF11 RANGAP1 ZBTB33 DSP CPSF6 ATG2B ZDBF2 MUC13 SHTN1 MYOF TLN1 TANC1 SNRNP200 | 1.21e-08 | 256 | 264 | 14 | 33397691 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | ATP5PO CENPE NT5C3A RABGAP1 SUCLA2 ME2 ITPR1 BLM DECR1 RAB10 PARP1 FDX1 DDX54 TTC13 ATXN10 MTCH1 RAB5C RAF1 UBQLN2 CPSF6 UBR4 ATG2B ELP1 FNDC3A CCT2 ZDBF2 ARAF CCT5 TMX4 TANC1 NUP188 EIF2AK2 SLC33A1 FTSJ3 | 1.33e-08 | 1496 | 264 | 34 | 32877691 |
| Pubmed | 1.37e-08 | 58 | 264 | 8 | 11856727 | ||
| Pubmed | USP34 TRIO UBQLN4 ACTN4 ACTN1 USP9Y JAK1 PARP1 AP2A1 COG1 PKM TLN2 DCLK2 ATXN10 UTRN RAB5B RAB6A TARS1 AGAP1 UBQLN2 DSP UBR4 GAS7 CCT2 SHTN1 ARHGAP5 SLF2 IFT122 WDFY3 SNRNP200 DCLK1 | 1.61e-08 | 1285 | 264 | 31 | 35914814 | |
| Pubmed | 1.84e-08 | 12 | 264 | 5 | 19717423 | ||
| Pubmed | USP34 RIPOR2 CENPN ACTN4 CLASP2 COPS2 ME2 ITPR1 SYT1 UTRN KIF11 PRAMEF33 CPSF6 PHTF2 G2E3 ANKRD50 ARPC5 ARHGAP5 SH3PXD2B SLC44A1 WDHD1 TET1 NFXL1 TMPRSS2 NUP188 DEDD SLC33A1 DCLK1 | 2.02e-08 | 1084 | 264 | 28 | 11544199 | |
| Pubmed | 2.35e-08 | 62 | 264 | 8 | 11773082 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | EFTUD2 JAK1 PARP1 AP2A2 DDX54 PKM POLR1B HEATR5B KIF11 NOC3L SRBD1 PABPC1 CCT5 EIF2AK2 FTSJ3 | 2.41e-08 | 316 | 264 | 15 | 31665637 |
| Pubmed | ACTN4 CLASP2 ACTN1 EFTUD2 PARP1 PKM ATXN10 TARS1 RAB5C KIF11 RANGAP1 UBR4 ELP1 CCT2 PABPC1 WDHD1 CCT5 TLN1 PRMT3 NUP188 SNRNP200 | 2.41e-08 | 638 | 264 | 21 | 33239621 | |
| Pubmed | HDAC4 TRIO CENPE CLASP2 RAB3C EFTUD2 RAB10 PARP1 AP2A1 AP2A2 SVIL SYT1 TLN2 KIF11 TRIM46 RANGAP1 ZNF618 PKP4 UBR4 GRIK3 SHTN1 PABPC1 SH3PXD2B PABPC3 WDFY3 DCLK1 | 2.79e-08 | 963 | 264 | 26 | 28671696 | |
| Pubmed | HDAC4 INPPL1 PABPC4 ACTN4 CLASP2 EFTUD2 RAB10 PARP1 AP2A1 AP2A2 SVIL UGDH DDX54 PKM TARS1 RAF1 RBM15 RANGAP1 CPSF6 PKP4 CCT2 PABPC1 ARAF DNAH1 MYOF CCT5 TLN1 WDR82 EIF2AK2 FTSJ3 | 2.97e-08 | 1247 | 264 | 30 | 27684187 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH7 ATP5PO LDHAL6A PABPC4 ACTN4 ACTN1 ACTN3 SUCLA2 SURF4 UGDH PKM ATXN10 RAB5A RAB5B RAB5C DSP UBR4 CCT2 PABPC1 CCT5 PABPC3 | 3.06e-08 | 647 | 264 | 21 | 26618866 |
| Pubmed | USP34 ATP5PO PABPC4 CLASP2 ABCB1 EFTUD2 PARP1 DDX54 SCAPER PKM RAB5A RAB6A KIF11 RBM15 UBQLN2 BZW2 CPSF6 NOC3L PCDHAC1 CCT2 PABPC1 WDHD1 CCT5 WDR82 EIF2AK2 SNRNP200 | 3.29e-08 | 971 | 264 | 26 | 33306668 | |
| Pubmed | PABPC4 PARP1 GSDME AP2A1 SURF4 ATXN10 ALDH1A3 RAB5A RAB5B AGAP1 RAF1 UBQLN2 UBR4 SHTN1 SLC44A1 | 3.48e-08 | 325 | 264 | 15 | 36168628 | |
| Pubmed | ATP5PO PABPC4 ACTN4 ACTN1 ME2 AP2A1 AP2A2 MOGS UGP2 PKM ALDH1A3 UTRN TARS1 DSP PKP4 UBR4 CCT2 PABPC1 CCT5 PABPC3 TLN1 RAB21 EIF2AK2 SNRNP200 | 3.76e-08 | 844 | 264 | 24 | 25963833 | |
| Pubmed | ATP5PO CLASP2 SUCLA2 ME2 ITPR1 EFTUD2 BLM PARP1 STXBP3 MOGS SURF4 DDX54 TTC13 SEMA6A ATXN10 TARS1 PMS1 RANGAP1 ERO1B PKP4 UBR4 NOC3L ELP1 FNDC3A TLN1 TMX4 NFXL1 TANC1 IFT122 SNRNP200 SLC33A1 EDRF1 FTSJ3 | 3.89e-08 | 1487 | 264 | 33 | 33957083 | |
| Pubmed | PABPC4 CLASP2 EFTUD2 JAK1 PARP1 PKM KIF11 RBM15 DSP CPSF6 UBR4 CCT2 SRBD1 PABPC1 CCT5 WDR82 PRMT3 EIF2AK2 SNRNP200 | 5.55e-08 | 551 | 264 | 19 | 34728620 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ERCC6 CENPE MYO7A CLASP2 ALDH1L1 USP9Y COPS2 TRRAP BLM DDX54 PLCB4 CACNA1C RBM15 CPSF6 ARAF RGS12 DNAH12 CCT5 | 6.04e-08 | 497 | 264 | 18 | 36774506 |
| Pubmed | MYH7 TRIO ACTN4 CLASP2 ACTN3 GSDME UGDH UGP2 PKM TRIM63 ATXN10 UTRN COL6A3 DSP ELP1 GAS7 ANKRD50 TLN1 | 6.04e-08 | 497 | 264 | 18 | 23414517 | |
| Pubmed | Cytoplasmic control of Rab family small GTPases through BAG6. | 6.85e-08 | 15 | 264 | 5 | 30804014 | |
| Pubmed | ATP5PO TRIO PABPC4 ACTN4 PIGG TRRAP JAK1 PARP1 FAT1 AP2A1 MOGS SURF4 TTC13 PLCB4 RAB5B RAB6A HSD17B8 RAB5C KIF11 UBQLN2 DSP UBR4 CCT2 PABPC1 ARPC5 MYOF CCT5 NUP188 RAB21 EIF2AK2 | 7.00e-08 | 1297 | 264 | 30 | 33545068 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ATP5PO PABPC4 ACTN4 ACTN1 ITPR1 EFTUD2 RAB10 PARP1 AP2A1 AP2A2 SVIL DDX54 PKM POLR1B RBM15 RANGAP1 DSP CPSF6 NOC3L CCT2 PABPC1 CCT5 EIF2AK2 SNRNP200 FTSJ3 | 8.35e-08 | 949 | 264 | 25 | 36574265 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | ATP5PO HDAC4 MYO7A CDH23 ACTN4 CLASP2 ACTN1 COPS2 EFTUD2 BLM TBC1D32 RAB10 AP2A1 AP2A2 SURF4 ATXN10 RAB6A AGAP1 NPHP1 RAF1 BZW2 CPSF6 ATG2B NEK7 ARAF IFT122 RAB21 SNRNP200 DCLK1 EDRF1 | 1.04e-07 | 1321 | 264 | 30 | 27173435 |
| Pubmed | USP34 UBQLN4 RABGAP1 MCCC1 UTRN KIF11 RAF1 ZBTB33 DSP UBR4 ATG2B ZDBF2 SHTN1 ARAF KMT2D TET1 | 1.59e-07 | 418 | 264 | 16 | 34709266 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | USP34 CNTNAP3B NT5C3A CNTNAP3 CLASP2 BLM JAK1 FAT1 STXBP3 AP2A1 COG1 SURF4 MTCH1 RAB5A RAB5B HSD17B8 DPY19L2 MUC13 SHTN1 MYOF SMS NUP188 WDFY3 TRIM47 RAB21 SLC33A1 | 1.85e-07 | 1061 | 264 | 26 | 33845483 |
| Pubmed | CENPE PABPC4 ACTN1 ACTN3 EFTUD2 PARP1 AP2A1 PKM BZW2 CCT2 PABPC1 CCT5 SNRNP200 | 1.86e-07 | 271 | 264 | 13 | 26816005 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | TRIO CENPE ACTN4 MCCC1 DECR1 STXBP3 MTUS1 SVIL RANGAP1 DSP PKP4 NOC3L CCT2 ARPC5 ARAF RGS12 ARHGAP5 SH3PXD2B CCT5 TLN1 TANC1 RAB21 FTSJ3 | 1.88e-07 | 853 | 264 | 23 | 28718761 |
| Pubmed | MYH7 INPPL1 ACTN4 ACTN1 COPS2 DECR1 PARP1 PKM UTRN TARS1 CPSF6 CCT2 PABPC1 ARPC5 AARSD1 CCT5 TLN1 SNRNP200 | 1.95e-07 | 538 | 264 | 18 | 28524877 | |
| Pubmed | TRIO RPS4Y1 ACTN4 RABGAP1 MCCC1 SUCLA2 ITPR1 DECR1 AP2A2 PKM SYT1 TLN2 DCLK2 MTCH1 RPS4Y2 RANGAP1 DSP CPSF6 UBR4 ATG2B ZDBF2 RAB6B CCT5 TMX4 CNTNAP2 RAB21 DCLK1 | 2.05e-07 | 1139 | 264 | 27 | 36417873 | |
| Pubmed | ATP5PO ACOT13 ACTN4 ACTN1 MCCC1 SUCLA2 ME2 DECR1 PARP1 MOGS FDX1 PKM AP1S2 UTRN RAB5A RAB5B RAB6A RAB5C PMS1 THUMPD2 MYOF TMX4 RAB21 | 2.12e-07 | 859 | 264 | 23 | 31536960 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 INPPL1 PABPC4 ACTN4 RABGAP1 ACTN1 COPS2 EFTUD2 UGDH UGP2 PKM ATXN10 TARS1 RANGAP1 UBQLN2 BZW2 UBR4 ELP1 CCT2 SHTN1 PABPC1 ARPC5 AARSD1 WDHD1 CCT5 TLN1 SMS PRMT3 NUP188 TRIM47 SNRNP200 | 2.53e-07 | 1455 | 264 | 31 | 22863883 |
| Pubmed | CENPE RPS4Y1 CLASP2 PIGG F5 ITPR1 EFTUD2 PARP1 AP2A1 MOGS DDX54 ATXN10 HEATR5B KIF11 BZW2 CPSF6 MPDU1 UBR4 FNDC3A PABPC1 SLC44A1 PRKAG1 NFXL1 IFT122 NUP188 EIF2AK2 SLC33A1 | 3.35e-07 | 1168 | 264 | 27 | 19946888 | |
| Pubmed | ACTN4 RAB10 STXBP3 UGP2 PKM RAB5A RAB5B RAB6A TARS1 RAB5C DSP SLC44A2 CCT2 ARPC5 SLC44A1 CCT5 TLN1 RAB21 | 3.99e-07 | 565 | 264 | 18 | 20458337 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | ATP5PO NT5C3A PABPC4 SUCLA2 EFTUD2 PARP1 STXBP3 PKM POLR1B ATXN10 RAB5B TARS1 RAB5C RAF1 RBM15 RANGAP1 ISYNA1 ZBTB33 DSP UBR4 ELP1 CCT2 PABPC1 CCT5 PABPC3 NFXL1 NUP188 SNRNP200 | 4.20e-07 | 1257 | 264 | 28 | 37317656 |
| Pubmed | RABGAP1 ITPR1 GSDME SURF4 RAB6A RANGAP1 ZBTB33 DSP ATG2B FNDC3A ZDBF2 MUC13 SHTN1 SH3PXD2B TLN1 NFXL1 TANC1 SLC33A1 | 4.30e-07 | 568 | 264 | 18 | 37774976 | |
| Pubmed | 4.32e-07 | 3 | 264 | 3 | 21940797 | ||
| Pubmed | α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse. | 4.32e-07 | 3 | 264 | 3 | 21784188 | |
| Pubmed | Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. | 4.32e-07 | 3 | 264 | 3 | 22622570 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ATP5PO PABPC4 ACTN4 CLASP2 ACTN1 EFTUD2 DECR1 PARP1 AP2A1 AP2A2 MOGS DDX54 PKM TARS1 RAB5C KIF11 RANGAP1 DSP CPSF6 UBR4 ELP1 CCT2 PABPC1 CCT5 TLN1 PRKAG1 TRIM47 EIF2AK2 SNRNP200 FTSJ3 | 4.45e-07 | 1415 | 264 | 30 | 28515276 |
| Pubmed | 4.47e-07 | 21 | 264 | 5 | 17562788 | ||
| Pubmed | ERCC6 ATP5PO PABPC4 CLASP2 ACTN1 PIGG TRRAP BLM RAB10 POLR1B HEATR5B UTRN RAB5C AGAP1 EP400 CPSF6 PKP4 NOC3L CLDN3 SRBD1 RAB6B ARPC5 ARAF MYOF CCT5 TLN1 WDR82 TANC1 EIF2AK2 DCLK1 EDRF1 | 4.67e-07 | 1497 | 264 | 31 | 31527615 | |
| Pubmed | TRIO PABPC4 BPIFB1 COPS2 PARP1 AP2A1 AP2A2 SVIL DDX54 RAB5C PMS1 RAF1 PKP4 UBR4 NOC3L ARAF TLN1 NUP188 FTSJ3 | 4.75e-07 | 634 | 264 | 19 | 34591612 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | UTP6 USP34 ATP5PO ACTN4 PTPN3 AP2A1 UGDH DDX54 TTC13 ATXN10 UTRN RAB5A RAB5C KIF11 RAF1 BZW2 UBR4 ELP1 ANKRD50 ARAF CCT5 SMS NUP188 SNRNP200 | 5.10e-07 | 974 | 264 | 24 | 28675297 |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | ATP5PO UBQLN4 RAB10 STXBP3 SURF4 PKM AP1S2 TTC13 RAB5A RAB6A RAB5C UBQLN2 CCT2 RAB6B CCT5 NFXL1 RAB21 | 5.32e-07 | 516 | 264 | 17 | 36610398 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | ATP5PO PABPC4 ACTN4 ACTN1 RAB10 PARP1 AP2A1 AP2A2 SVIL PKM TDRD6 DSP BZW2 CCT2 MUC13 PABPC1 ARPC5 CCT5 | 5.82e-07 | 580 | 264 | 18 | 35676659 |
| Pubmed | ATP5PO PABPC4 PARP1 MOGS SURF4 UGDH DDX54 PKM UTRN RAB5C RBM15 DSP CPSF6 UBR4 PABPC1 KMT2D CCT5 TLN1 RAB21 SNRNP200 | 6.34e-07 | 711 | 264 | 20 | 33022573 | |
| Pubmed | USP34 ATP5PO NT5C3A PABPC4 PIGG MCCC1 SUCLA2 COPS2 ITPR1 EFTUD2 DECR1 PARP1 AP2A2 COG1 SURF4 DDX54 RAF1 RANGAP1 BZW2 UBR4 NOC3L ELP1 CCT2 MUC13 ARPC5 MYOF CCT5 TLN1 NUP188 SNRNP200 | 6.40e-07 | 1440 | 264 | 30 | 30833792 | |
| Pubmed | 6.58e-07 | 10 | 264 | 4 | 10329441 | ||
| Pubmed | Genome-wide association scan for five major dimensions of personality. | 6.58e-07 | 10 | 264 | 4 | 18957941 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | ACTN4 MCCC1 EFTUD2 BLM PARP1 DDX54 PKM PMS1 RANGAP1 EP400 DSP CCT2 CCT5 SNRNP200 | 7.17e-07 | 357 | 264 | 14 | 37059091 |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | LDHAL6A CEL ACTN4 ACTN1 ALDH1L1 ACTN3 ABCB1 RAB10 UGDH UGP2 PKM ALDH1A3 RAB5B RAB5C COL6A3 SLC44A2 CCT2 PABPC1 MYOF PABPC3 TLN1 TSPAN8 TMPRSS2 SMS RAB21 | 7.71e-07 | 1070 | 264 | 25 | 23533145 |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | ATP5PO BPIFB1 RAB10 PTPN3 AP2A2 POLR1B ATXN10 UTRN MTCH1 RAB5A RAB5B RAB5C NIPAL4 BZW2 ATG2B NEK7 ELP1 ANKRD50 ZFPM2 LMBR1L TMX4 LACRT FTSJ3 | 8.51e-07 | 931 | 264 | 23 | 27432908 |
| Pubmed | MAGEB2 ATP5PO PABPC4 USP9Y ME2 EFTUD2 PARP1 AP2A2 MOGS SURF4 PKM RAF1 CPSF6 CCT2 PABPC1 CCT5 WDR82 NUP188 EIF2AK2 SNRNP200 | 8.56e-07 | 725 | 264 | 20 | 27025967 | |
| Pubmed | UTP6 ACTN4 ACTN1 F5 EFTUD2 DECR1 PARP1 AP2A1 AP2A2 SVIL POLR1B RBM15 RANGAP1 PABPC1 ARPC5 MYOF NUP188 EIF2AK2 SNRNP200 | 8.65e-07 | 660 | 264 | 19 | 32780723 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | MCCC1 ME2 EFTUD2 PARP1 PKM UTRN KIF11 PMS1 RANGAP1 ISYNA1 ZBTB33 EP400 DSP CPSF6 ATG2B NOC3L CASP3 CCT2 SHTN1 PABPC1 TLN1 SNRNP200 FTSJ3 | 8.99e-07 | 934 | 264 | 23 | 33916271 |
| Pubmed | ACTN4 GSDME TARS1 KIF11 RANGAP1 ZBTB33 ATG2B SHTN1 MYOF TLN1 TANC1 | 9.19e-07 | 216 | 264 | 11 | 31519766 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | BPIFB1 ACTN1 ALDH1L1 SUCLA2 ABCB1 RAB10 FAT1 MOGS UGP2 PKM UTRN RAB5B RAB5C COL6A3 DSP SLC44A2 CCT2 ARPC5 MYOF SLC44A1 CCT5 TLN1 TMPRSS2 RAB21 | 1.07e-06 | 1016 | 264 | 24 | 19056867 |
| Pubmed | ATP5PO PABPC4 ACTN4 ACTN1 MCCC1 ABCB1 EFTUD2 PARP1 STXBP3 SURF4 TARS1 MPDU1 PABPC1 TLN1 NUP188 RAB21 | 1.10e-06 | 484 | 264 | 16 | 31995728 | |
| Pubmed | PIGG MCCC1 SUCLA2 DECR1 RAB10 BPNT1 FAT1 STXBP3 COG1 SURF4 DDX54 RAB5B RAB6A RAB5C RPS4Y2 RBM15 PKP4 FNDC3A RAB6B NFXL1 WDR82 RAB21 SLC33A1 | 1.24e-06 | 952 | 264 | 23 | 38569033 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.25e-06 | 179 | 264 | 10 | 36261009 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | PABPC4 CLASP2 EFTUD2 AP2A1 AP2A2 MOGS DDX54 POLR1B KIF11 RBM15 DSP CPSF6 NOC3L CCT2 SRBD1 CCT5 PABPC3 WDR82 SNRNP200 | 1.29e-06 | 678 | 264 | 19 | 30209976 |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | USP34 PABPC4 CLASP2 USP9Y PARP1 PKM RAF1 BZW2 ZNF618 CCT2 CCT5 PRKAG1 SMS WDFY3 EIF2AK2 | 1.32e-06 | 432 | 264 | 15 | 23455922 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.46e-06 | 182 | 264 | 10 | 30711629 | |
| Pubmed | Assessment of a polymorphism of SDK1 with hypertension in Japanese Individuals. | 1.51e-06 | 142 | 264 | 9 | 19851296 | |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | ATP5PO TRIO UBQLN4 CLASP2 ACTN1 ALDH1L1 PARP1 GFOD1 PKM SYT1 RAB6A RANGAP1 UBQLN2 CCT2 PABPC1 TLN1 DCLK1 | 1.55e-06 | 558 | 264 | 17 | 35063084 |
| Pubmed | Association of genetic variants with hemorrhagic stroke in Japanese individuals. | 1.61e-06 | 143 | 264 | 9 | 20198315 | |
| Interaction | EED interactions | UTP6 ATP5PO TRIO ACTN4 ACTN1 TRRAP EFTUD2 SLC35G1 BPNT1 PARP1 AP2A1 AP2A2 MOGS SURF4 SVIL DDX54 PKM TRIM63 ATXN10 RAB5A RAB5B TARS1 RAB5C KIF11 RBM15 RANGAP1 EP400 DSP CPSF6 PKP4 UBR4 NOC3L ELP1 CCT2 PABPC1 ARPC5 CCT5 TLN1 PRKAG1 TANC1 NUP188 SNRNP200 FTSJ3 | 2.23e-07 | 1445 | 260 | 43 | int:EED |
| Interaction | RAB6A interactions | RABGAP1 TRRAP TBC1D32 RAB5A RAB6A RAB5C NPHP1 RAF1 RAB6B LMBR1L SYTL5 TMPRSS2 | 3.01e-07 | 141 | 260 | 12 | int:RAB6A |
| Interaction | AGR2 interactions | HDAC4 UBQLN4 ACTN4 ACTN1 ALDH1L1 MCCC1 EFTUD2 RAB10 PARP1 STXBP3 AP2A1 AP2A2 MOGS PKM UTRN RAB5A RAB5B RAB6A TARS1 RAB5C UBQLN2 DSP CPSF6 UBR4 CCT2 PABPC1 DNAH1 MYOF CCT5 TLN1 SMS SNRNP200 | 4.85e-07 | 934 | 260 | 32 | int:AGR2 |
| Interaction | MCM2 interactions | ATP5PO PABPC4 ACTN4 ACTN1 TRRAP ME2 EFTUD2 PARP1 AP2A1 AP2A2 MOGS UGP2 PKM ALDH1A3 UTRN TARS1 EP400 DSP PKP4 UBR4 ATG2B ELP1 CCT2 PABPC1 DNAH1 WDHD1 CCT5 PABPC3 TLN1 PRKAG1 WDR82 RAB21 EIF2AK2 SNRNP200 DCLK1 | 5.08e-07 | 1081 | 260 | 35 | int:MCM2 |
| Interaction | KIF20A interactions | ATP5PO CENPE RPS4Y1 PABPC4 ACTN4 ACTN1 ACTN3 USP9Y TRRAP ITPR1 EFTUD2 BLM RAB10 PARP1 AP2A1 AP2A2 COG1 SVIL PKM POLR1B UTRN RAB6A RPS4Y2 RAF1 DSP PKP4 NOC3L RAB6B PABPC1 ARPC5 RGS12 PABPC3 SNRNP200 FTSJ3 | 7.84e-07 | 1052 | 260 | 34 | int:KIF20A |
| Interaction | CHM interactions | 8.66e-07 | 59 | 260 | 8 | int:CHM | |
| Interaction | ZNF746 interactions | ATP5PO RPS4Y1 PABPC4 ACTN1 MCCC1 EFTUD2 PARP1 AP2A1 MOGS DDX54 PKM RPS4Y2 NPHP1 NOC3L PABPC3 SNRNP200 FTSJ3 | 1.26e-06 | 326 | 260 | 17 | int:ZNF746 |
| Interaction | MTNR1B interactions | USP34 RIPOR2 UBQLN4 ACTN1 DISP3 TRIM46 UBQLN2 UBR4 ARAF TLN1 CDH4 | 1.46e-06 | 135 | 260 | 11 | int:MTNR1B |
| Interaction | BAP1 interactions | MYH7 PABPC4 ACTN4 CLASP2 ACTN1 ALDH1L1 COPS2 EFTUD2 RAB10 PARP1 FAT1 AP2A1 AP2A2 FDX1 SVIL UGP2 PKM TRIM63 ATXN10 TARS1 RAB5C KIF11 RAF1 RANGAP1 DSP CPSF6 UBR4 CCT2 SHTN1 PABPC1 ARPC5 CCT5 TLN1 SMS RAB21 EIF2AK2 SNRNP200 FTSJ3 | 2.47e-06 | 1314 | 260 | 38 | int:BAP1 |
| Interaction | GAPDH interactions | ATP5PO HDAC4 PABPC4 ACTN4 EFTUD2 PARP1 SVIL PKM TLN2 TARS1 RAF1 MAGEL2 UBQLN2 DSP CPSF6 GAS7 FNDC3A CCT2 PABPC1 ARPC5 LIG4 DNAH12 CCT5 TLN1 TET1 | 3.23e-06 | 686 | 260 | 25 | int:GAPDH |
| Interaction | KCTD13 interactions | ATP5PO TRIO MYO7A PABPC4 ACTN4 CLASP2 ACTN1 ALDH1L1 ACTN3 SUCLA2 RAB10 PARP1 AP2A1 AP2A2 SVIL SCAPER UGP2 PKM SYT1 TLN2 DCLK2 UTRN TARS1 RAB5C TRIM46 RAF1 DSP PKP4 ELP1 CCT2 PABPC1 ARPC5 ARHGAP5 SLC44A1 CCT5 TLN1 TANC1 SNRNP200 DCLK1 | 3.96e-06 | 1394 | 260 | 39 | int:KCTD13 |
| Interaction | GDI1 interactions | UBQLN4 ALDH1L1 RAB10 RAB33A TTC5 RAB5A RAB5B RAB6A RAB5C RAB6B RAB21 | 5.61e-06 | 155 | 260 | 11 | int:GDI1 |
| Interaction | HTT interactions | ATP5PO PABPC4 ACTN1 MCCC1 SUCLA2 TRRAP RAB3C ITPR1 RAB10 AP2A1 AP2A2 PKM SYT1 ATXN10 TDRD6 RAB5A RAB6A RANGAP1 STAB2 UBQLN2 CASP3 ELP1 CASP6 CCT2 RAB6B PABPC1 CCT5 WDR82 EIF2AK2 DCLK1 | 5.73e-06 | 949 | 260 | 30 | int:HTT |
| Interaction | CIT interactions | UTP6 RPS4Y1 PABPC4 ACTN4 CLASP2 ACTN1 ACTN3 TRRAP EFTUD2 RAB10 AP2A1 AP2A2 MOGS SURF4 SVIL POLR1B RAB5A KIF11 RPS4Y2 RAF1 RBM15 RANGAP1 HTR1B EP400 DSP MPDU1 UBR4 NOC3L CCT2 SRBD1 PABPC1 ARPC5 DNAH12 CCT5 PABPC3 NUP188 EIF2AK2 SNRNP200 FTSJ3 | 9.95e-06 | 1450 | 260 | 39 | int:CIT |
| Interaction | WDR76 interactions | MAGEB2 PABPC4 UBQLN4 TRRAP PARP1 GFOD1 POLR1B UTRN KIF11 RAF1 RANGAP1 EP400 DSP CPSF6 CCT2 CCT5 SNRNP200 | 1.08e-05 | 383 | 260 | 17 | int:WDR76 |
| Interaction | HSF1 interactions | PECR PABPC4 ACTN4 TRRAP CC2D2B EFTUD2 PARP1 MOGS COG1 UGDH PKM TARS1 RAB5C EP400 DSP CPSF6 NEK7 PABPC1 ARAF MYOF CCT5 SNRNP200 | 1.48e-05 | 609 | 260 | 22 | int:HSF1 |
| Interaction | LMBR1L interactions | UTP6 ATP5PO NT5C3A UBQLN4 RAB10 STXBP3 AP2A1 MOGS COG1 SURF4 TTC13 ATXN10 HEATR5B MTCH1 RAB6A TARS1 KIF11 RANGAP1 UBQLN2 BZW2 UBR4 NOC3L ELP1 FNDC3A LMBR1L TLN1 NFXL1 NUP188 SLC33A1 | 1.48e-05 | 946 | 260 | 29 | int:LMBR1L |
| Interaction | OBSL1 interactions | UTP6 ATP5PO ACTN4 ACTN1 TRRAP EFTUD2 PARP1 AP2A1 DDX54 PKM UTRN RAF1 RBM15 RANGAP1 EP400 DSP CPSF6 TSGA10 CCT2 PABPC1 DNAH1 CCT5 LMBR1L TLN1 NUP188 EIF2AK2 SNRNP200 FTSJ3 | 1.67e-05 | 902 | 260 | 28 | int:OBSL1 |
| Interaction | ISG15 interactions | ACTN4 ACTN1 EFTUD2 JAK1 PARP1 AP2A1 AP2A2 UGDH DDX54 UGP2 PKM ALDH1A3 TARS1 CCT2 PABPC1 MYOF EIF2AK2 SNRNP200 FTSJ3 | 2.46e-05 | 494 | 260 | 19 | int:ISG15 |
| Interaction | PHLPP1 interactions | PKM KIF11 RBM15 RANGAP1 ZBTB33 DSP CPSF6 ATG2B ZDBF2 MUC13 SHTN1 MYOF TLN1 TANC1 SNRNP200 | 3.03e-05 | 333 | 260 | 15 | int:PHLPP1 |
| Interaction | GDI2 interactions | TRRAP RAB10 PARP1 RAB33A RAB5A RAB5B RAB6A RAB5C NEK7 RAB6B RAB21 | 3.28e-05 | 187 | 260 | 11 | int:GDI2 |
| Interaction | GSK3A interactions | TRIO INPPL1 PABPC4 ACTN4 CLASP2 PARP1 MTUS1 DDX54 UTRN MTCH1 ATG2B ZDBF2 SRBD1 PABPC1 CCT5 LMBR1L PRMT3 TANC1 | 3.60e-05 | 464 | 260 | 18 | int:GSK3A |
| Interaction | SIRT7 interactions | UTP6 USP34 PABPC4 ACTN4 ACTN1 TRRAP ME2 BLM DDX54 UTRN RAF1 RBM15 RANGAP1 DSP UBR4 NOC3L ELP1 CCT2 PABPC1 CCT5 TLN1 NUP188 SNRNP200 FTSJ3 | 3.78e-05 | 744 | 260 | 24 | int:SIRT7 |
| Interaction | CASP10 interactions | 4.82e-05 | 51 | 260 | 6 | int:CASP10 | |
| Interaction | HSPB1 interactions | HDAC4 PABPC4 ACTN4 ACTN1 MCCC1 TRRAP EFTUD2 PTPN3 UGDH PKM TRIM63 ATXN10 TMCO3 RAB5A TARS1 RAF1 CASP3 PABPC1 ARAF AARSD1 PIM3 LMBR1L SNRNP200 | 4.95e-05 | 708 | 260 | 23 | int:HSPB1 |
| Interaction | HSP90AB1 interactions | HDAC4 INPPL1 INSRR ACTN4 ACTN1 COPS2 EFTUD2 PARP1 MOGS SVIL PKM DCLK2 SDR16C5 NPHP1 ANKK1 RAF1 UBQLN2 DSP UBR4 FNDC3A CCT2 ARAF CCT5 LMBR1L TLN1 TSHZ1 SLC33A1 EDRF1 | 5.04e-05 | 960 | 260 | 28 | int:HSP90AB1 |
| Interaction | MAPT interactions | ATP5PO TRIO UBQLN4 CLASP2 ACTN1 ALDH1L1 USP9Y RAB3C RAB10 PARP1 AP2A1 AP2A2 GFOD1 PKM SYT1 DCLK2 RAB5A RAB6A RAB5C RANGAP1 UBQLN2 CASP3 CASP4 CASP6 GAS7 CCT2 RAB6B PABPC1 CCT5 TLN1 DCLK1 | 5.15e-05 | 1119 | 260 | 31 | int:MAPT |
| Interaction | SLX4 interactions | ERCC6 ACTN4 MCCC1 EFTUD2 BLM PARP1 AP2A1 AP2A2 DDX54 PKM PMS1 RBM15 RANGAP1 EP400 DSP CCT2 CCT5 SLF2 NUP188 SNRNP200 | 5.73e-05 | 572 | 260 | 20 | int:SLX4 |
| Interaction | MTNR1A interactions | 6.13e-05 | 166 | 260 | 10 | int:MTNR1A | |
| Interaction | DDRGK1 interactions | MAGEB2 ATP5PO PABPC4 CLASP2 EFTUD2 RAB10 PARP1 AP2A1 AP2A2 MOGS SURF4 DDX54 PKM ATXN10 MTCH1 RAB5A RAB5C KIF11 RBM15 RANGAP1 CPSF6 UBR4 NOC3L CCT2 SRBD1 PABPC1 CCT5 LMBR1L NFXL1 TMPRSS2 EIF2AK2 SNRNP200 FTSJ3 | 7.28e-05 | 1249 | 260 | 33 | int:DDRGK1 |
| Interaction | HDAC6 interactions | RIPOR2 ATP5PO PABPC4 ACTN4 ACTN1 TRRAP EFTUD2 SLC35G1 RAB10 PARP1 FAT1 AP2A1 AP2A2 SVIL PKM POLR1B TDRD6 MOCS1 EP400 DSP BZW2 CCT2 MUC13 PABPC1 ARPC5 CCT5 FTSJ3 | 7.34e-05 | 929 | 260 | 27 | int:HDAC6 |
| Interaction | ITGB3 interactions | 7.48e-05 | 170 | 260 | 10 | int:ITGB3 | |
| Interaction | NPM1 interactions | MYH7 MAGEB2 PABPC4 COPS2 TRRAP EFTUD2 DECR1 JAK1 IGSF10 PARP1 CFAP54 MOGS SURF4 DDX54 PKM UTRN KIF11 RAF1 STAB2 UBQLN2 DSP CPSF6 NOC3L CCT2 PABPC1 ARAF ARHGAP5 CNTNAP2 RAB21 EIF2AK2 SNRNP200 FTSJ3 | 8.07e-05 | 1201 | 260 | 32 | int:NPM1 |
| Interaction | FBXO22 interactions | ERCC6 CENPE MYO7A CLASP2 ALDH1L1 USP9Y COPS2 TRRAP EFTUD2 BLM DDX54 PLCB4 CACNA1C RBM15 CPSF6 ARAF RGS12 DNAH12 CCT5 | 8.11e-05 | 540 | 260 | 19 | int:FBXO22 |
| Interaction | CFTR interactions | MYH7 MAGEB2 ATP5PO LDHAL6A PABPC4 ACTN4 ACTN1 ACTN3 MCCC1 SUCLA2 JAK1 PARP1 GSDME AP2A1 SURF4 SVIL UGDH PKM ATXN10 RAB5A RAB5B RAB5C RPS4Y2 DSP UBR4 CCT2 MUC13 PABPC1 ARPC5 AARSD1 CCT5 LMBR1L PABPC3 TLN1 SLC33A1 DCLK1 SEMA3E | 8.14e-05 | 1480 | 260 | 37 | int:CFTR |
| Interaction | CARM1 interactions | CENPE RABGAP1 EFTUD2 PARP1 MOGS UGP2 UTRN RAB5A RAB5C RAF1 PABPC1 CCT5 SMS SLC33A1 | 8.98e-05 | 325 | 260 | 14 | int:CARM1 |
| Interaction | ITGA4 interactions | ATP5PO INPPL1 PABPC4 ACTN4 EFTUD2 DECR1 RAB10 PARP1 AP2A1 PKM TARS1 RAB5C UBR4 CCT2 PABPC1 CCT5 TLN1 NUP188 SNRNP200 | 9.60e-05 | 547 | 260 | 19 | int:ITGA4 |
| Interaction | LZTR1 interactions | 9.68e-05 | 111 | 260 | 8 | int:LZTR1 | |
| Interaction | ACE2 interactions | ATP5PO RPS4Y1 PABPC4 ACTN4 RABGAP1 ACTN1 EFTUD2 DECR1 RAB10 PARP1 PTPN3 AP2A1 AP2A2 UGDH DDX54 PKM RAB6A TARS1 RAB5C CACNA1C RBM15 ISYNA1 DSP UBR4 CCT2 PABPC1 MYOF TLN1 TMPRSS2 SNRNP200 | 1.00e-04 | 1106 | 260 | 30 | int:ACE2 |
| Interaction | CHML interactions | 1.00e-04 | 58 | 260 | 6 | int:CHML | |
| Interaction | CUL7 interactions | ERCC6 ATP5PO HDAC4 PABPC4 ACTN4 ACTN1 ABCB1 EFTUD2 RAB10 PARP1 SURF4 PKM RAB5B TARS1 RAB5C RBM15 RANGAP1 DSP CPSF6 CCT2 PABPC1 CCT5 TLN1 RAB21 SNRNP200 | 1.04e-04 | 845 | 260 | 25 | int:CUL7 |
| Interaction | AAGAB interactions | 1.07e-04 | 37 | 260 | 5 | int:AAGAB | |
| Interaction | DUX4 interactions | PABPC4 ACTN1 EFTUD2 PARP1 AP2A1 PKM BZW2 CCT2 PABPC1 CCT5 SNRNP200 | 1.11e-04 | 214 | 260 | 11 | int:DUX4 |
| Interaction | CASP5 interactions | 1.13e-04 | 8 | 260 | 3 | int:CASP5 | |
| Interaction | LDHA interactions | LDHAL6A RABGAP1 EFTUD2 PKM RAB5A RAB5C KIF11 NPHP1 RAF1 MAGEL2 FNDC3A RAB6B LIG4 SMS RAB21 | 1.16e-04 | 375 | 260 | 15 | int:LDHA |
| Interaction | RAB1B interactions | TRRAP RAB10 MOGS RAB5A RAB5B RAB6A RAB5C RAF1 DSP BZW2 RAB6B TMPRSS2 | 1.17e-04 | 253 | 260 | 12 | int:RAB1B |
| Interaction | FASN interactions | INPPL1 CLASP2 TRRAP EFTUD2 RAB10 PARP1 GSDME MOGS DDX54 SCAPER UGP2 MTCH1 RAB5C KIF11 RAF1 DSP MPDU1 UBR4 NEK7 SHTN1 PABPC1 PIM3 LMBR1L PRKAG1 WDR82 SMS NUP188 SLC33A1 SOWAHB | 1.17e-04 | 1062 | 260 | 29 | int:FASN |
| Interaction | MPDU1 interactions | 1.22e-04 | 60 | 260 | 6 | int:MPDU1 | |
| Interaction | CUL4A interactions | USP34 ERCC6 HDAC4 INPPL1 PABPC4 COPS2 EFTUD2 BPNT1 PARP1 UGDH PKM TMCO3 RAB5C RAF1 ISYNA1 UBR4 NLRP1 FNDC3A PABPC1 RGS12 WDHD1 CCT5 TET1 WDR82 SNRNP200 | 1.23e-04 | 854 | 260 | 25 | int:CUL4A |
| Interaction | SOHLH1 interactions | 1.24e-04 | 115 | 260 | 8 | int:SOHLH1 | |
| Interaction | NR2C2 interactions | UTP6 HDAC4 RPS4Y1 PABPC4 MCCC1 SUCLA2 EFTUD2 DECR1 RAB10 PARP1 AP2A1 AP2A2 SURF4 DDX54 PKM POLR1B RAB5A RAB5C RBM15 EP400 CPSF6 MPDU1 UBR4 NOC3L CCT2 RAB6B PABPC1 CCT5 PRKAG1 WDR82 PRMT3 RAB21 EIF2AK2 SNRNP200 FTSJ3 | 1.35e-04 | 1403 | 260 | 35 | int:NR2C2 |
| Interaction | FBXO42 interactions | CENPE RABGAP1 MCCC1 COPS2 PARP1 RAB6A EP400 DSP ELP1 CCT2 CCT5 TANC1 | 1.45e-04 | 259 | 260 | 12 | int:FBXO42 |
| Interaction | HMGN2 interactions | ANKRD31 PARP1 SVIL UTRN RAB5A TARS1 RAF1 MPDU1 G2E3 ARAF EIF2AK2 | 1.53e-04 | 222 | 260 | 11 | int:HMGN2 |
| Interaction | PRC1 interactions | UTP6 CENPE RPS4Y1 PABPC4 ACTN4 ACTN1 ACTN3 TRRAP EFTUD2 AP2A1 AP2A2 MOGS DDX54 ATXN10 RPS4Y2 RBM15 RANGAP1 DSP NOC3L CCT2 PABPC1 RGS12 CCT5 PABPC3 NUP188 SNRNP200 FTSJ3 | 1.57e-04 | 973 | 260 | 27 | int:PRC1 |
| Interaction | VCAM1 interactions | ATP5PO INPPL1 ACTN4 EFTUD2 DECR1 PARP1 AP2A1 TARS1 RAB5C UBR4 CCT2 PABPC1 CCT5 TLN1 NUP188 WDFY3 SNRNP200 | 1.57e-04 | 475 | 260 | 17 | int:VCAM1 |
| Interaction | GSK3B interactions | HDAC4 TRIO INPPL1 BPIFB1 ACTN4 CLASP2 ACTN1 COPS2 EFTUD2 PARP1 MOGS MTUS1 UGDH PKM ALDH1A3 UTRN BZW2 ATG2B CCT2 ZDBF2 PABPC1 MYOF LMBR1L PRMT3 TANC1 | 1.58e-04 | 868 | 260 | 25 | int:GSK3B |
| Interaction | CDC73 interactions | ACTN4 ACTN1 ACTN3 EFTUD2 RAB10 PARP1 PKM RAB5A RAB5C DSP CPSF6 TSGA10 CCT2 CCT5 WDR82 | 1.59e-04 | 386 | 260 | 15 | int:CDC73 |
| Interaction | TRIM28 interactions | UTP6 MAGEB2 ATP5PO HDAC4 PABPC4 CLASP2 SUCLA2 COPS2 TRRAP EFTUD2 PARP1 AP2A1 PKM AP1S2 POLR1B KIF11 RAF1 RANGAP1 ZBTB33 UBR4 CASP3 ELP1 FNDC3A CCT2 PABPC1 ARAF PIM3 WDHD1 CCT5 WDR82 SMS PRMT3 NUP188 RAB21 EIF2AK2 SNRNP200 | 1.63e-04 | 1474 | 260 | 36 | int:TRIM28 |
| Interaction | SIRT6 interactions | MYH7 ACTN1 TRRAP ITPR1 EFTUD2 BLM PARP1 FAT1 DDX54 POLR1B EP400 DSP NOC3L ELP1 ZDBF2 WDHD1 CCT5 NUP188 SNRNP200 FTSJ3 | 2.01e-04 | 628 | 260 | 20 | int:SIRT6 |
| Interaction | VCP interactions | ERCC6 HDAC4 ACTN4 RABGAP1 ACTN1 ITPR1 EFTUD2 BLM DECR1 RAB10 PARP1 PTPN3 AP2A2 UGDH DDX54 UGP2 PKM ATXN10 RAB5C RAF1 CACNA1C ISYNA1 UBQLN2 DSP BZW2 UBR4 FNDC3A CCT2 PABPC1 DDIAS CCT5 LMBR1L PRKAG1 WDR82 PRMT3 | 2.08e-04 | 1435 | 260 | 35 | int:VCP |
| Interaction | HSPA6 interactions | CPLANE2 INPPL1 PABPC4 FUNDC1 COPS2 EFTUD2 RAF1 DSP PABPC1 ARAF WDHD1 LMBR1L TLN1 | 2.15e-04 | 311 | 260 | 13 | int:HSPA6 |
| Interaction | YWHAH interactions | HDAC4 TRIO INPPL1 CLASP2 EFTUD2 PTPN3 MTUS1 SVIL DCLK2 UTRN TARS1 KIF11 ARAP2 AGAP1 RAF1 RBM15 DSP SHTN1 ARAF RGS12 SH3PXD2B LMBR1L SLF2 TET1 TANC1 RAB21 DCLK1 EDRF1 TPH1 | 2.19e-04 | 1102 | 260 | 29 | int:YWHAH |
| Interaction | NOMO3 interactions | 2.25e-04 | 67 | 260 | 6 | int:NOMO3 | |
| Interaction | RAB6C interactions | 2.38e-04 | 10 | 260 | 3 | int:RAB6C | |
| Interaction | BIRC3 interactions | UTP6 ATP5PO TRIO ACOT13 ACTN4 SUCLA2 ME2 EFTUD2 PARP1 AP2A1 MOGS DDX54 PKM TLN2 ATXN10 TDRD6 TARS1 KIF11 RAF1 RBM15 RANGAP1 DSP UBR4 CASP3 CCT2 PABPC1 CCT5 TLN1 WDR82 NUP188 EIF2AK2 SNRNP200 FTSJ3 | 2.48e-04 | 1334 | 260 | 33 | int:BIRC3 |
| Interaction | SUMO2 interactions | ERCC6 HDAC4 EFTUD2 BLM PARP1 PKM TRIM63 KIF11 RANGAP1 ZBTB33 EP400 UBR4 NEK7 CCT2 WDHD1 CCT5 TLN1 EIF2AK2 SNRNP200 | 2.58e-04 | 591 | 260 | 19 | int:SUMO2 |
| Interaction | HAX1 interactions | RABGAP1 ABCB1 TBC1D32 SVIL SYT1 RAB5A RAB6A RAF1 ATG2B ELP1 RAB6B ARAF NUP188 SLC33A1 DCLK1 | 2.59e-04 | 404 | 260 | 15 | int:HAX1 |
| Interaction | FN1 interactions | ACOT13 PABPC4 ACTN4 EFTUD2 DECR1 RAB10 PARP1 STXBP3 AP2A1 AP2A2 PKM ATXN10 TARS1 RAB5C COL4A4 RAF1 BZW2 CPSF6 CCT2 PABPC1 CCT5 TLN1 LACRT SNRNP200 | 2.77e-04 | 848 | 260 | 24 | int:FN1 |
| Interaction | RAC1 interactions | MAGEB2 TRIO INPPL1 JAK1 FAT1 STXBP3 AP2A2 MOGS PKM PLCB4 UTRN MTCH1 RAB5C ARAP2 AGAP1 RAF1 RBM15 PKP4 CASP3 CLDN3 MUC13 PABPC1 ARHGAP5 MYOF PRKAG1 TANC1 EIF2AK2 SLC33A1 | 2.78e-04 | 1063 | 260 | 28 | int:RAC1 |
| Interaction | DPP4 interactions | ATP5PO ACTN4 ACTN1 RAB10 MOGS GFOD1 SURF4 DDX54 TTC13 SEMA6A PLCB4 RAB6A RAF1 RBM15 ERO1B UBR4 | 2.84e-04 | 453 | 260 | 16 | int:DPP4 |
| Interaction | AKAP1 interactions | NT5C3A PABPC4 FUNDC1 ACTN1 TRRAP SURF4 MTCH1 RAB5A RAB6A RAB5C RAF1 UBR4 ATG2B CCT2 RAB6B PABPC1 NUP188 | 3.07e-04 | 503 | 260 | 17 | int:AKAP1 |
| Interaction | HERC2 interactions | HDAC4 PABPC4 BLM SURF4 RAB5A RAB5B KIF11 PMS1 RAF1 MPDU1 UBR4 FNDC3A SHTN1 PABPC1 ARAF RGS12 KMT2D | 3.07e-04 | 503 | 260 | 17 | int:HERC2 |
| Interaction | DYNLT1 interactions | CLASP2 ACTN1 MCCC1 BLM MTUS1 SVIL DDX54 PMS1 NOC3L AARSD1 FTSJ3 | 3.11e-04 | 241 | 260 | 11 | int:DYNLT1 |
| Interaction | PRKCZ interactions | ACTN4 JAK1 SLC35G1 FAT1 STXBP3 AP2A2 PKM TARS1 KIF11 RAF1 CPSF6 CASP3 CASP6 CCT2 CCT5 | 3.19e-04 | 412 | 260 | 15 | int:PRKCZ |
| Interaction | CTSD interactions | 3.28e-04 | 167 | 260 | 9 | int:CTSD | |
| Interaction | C11orf58 interactions | 3.37e-04 | 101 | 260 | 7 | int:C11orf58 | |
| Interaction | DNAAF10 interactions | 3.37e-04 | 133 | 260 | 8 | int:DNAAF10 | |
| Interaction | BCR interactions | INPPL1 TRRAP PTPN3 AP2A1 DDX54 UTRN RANGAP1 CPSF6 UBR4 WDR82 NUP188 | 3.46e-04 | 244 | 260 | 11 | int:BCR |
| Interaction | CCDC8 interactions | PABPC4 ACTN4 F5 EFTUD2 PARP1 SVIL PKM ATXN10 HEATR5B UTRN RAB5C EP400 DSP CPSF6 ELP1 CCT2 PABPC1 DNAH12 NUP188 SNRNP200 | 3.54e-04 | 656 | 260 | 20 | int:CCDC8 |
| Interaction | BRCA1 interactions | MAGEB2 ERCC6 TRIO PABPC4 ACTN3 ITPR1 EFTUD2 BLM JAK1 PARP1 AP2A1 DDX54 PKM TARS1 RAB5C KIF11 TRIM46 RANGAP1 ERO1B DSP CPSF6 UBR4 CASP3 CCT2 PABPC1 WDHD1 CCT5 SLF2 TLN1 TRIM47 SNRNP200 | 3.65e-04 | 1249 | 260 | 31 | int:BRCA1 |
| Interaction | CLINT1 interactions | MYH7 AP2A1 AP2A2 AP1S2 RAB5C RAF1 MAGEL2 UBQLN2 LMBR1L NFXL1 | 3.72e-04 | 207 | 260 | 10 | int:CLINT1 |
| Interaction | MRE11 interactions | ERCC6 UBQLN4 TRRAP EFTUD2 BLM PARP1 RAF1 MAGEL2 UBQLN2 CPSF6 LIG4 SMS | 3.73e-04 | 287 | 260 | 12 | int:MRE11 |
| Interaction | AURKB interactions | ATP5PO RPS4Y1 PABPC4 TRRAP TBC1D32 PARP1 MOGS SURF4 DDX54 PKM UTRN RPS4Y2 RAF1 RANGAP1 DSP UBR4 CCT2 PABPC1 LMBR1L PABPC3 NUP188 FTSJ3 | 3.74e-04 | 761 | 260 | 22 | int:AURKB |
| Interaction | RNF2 interactions | UTP6 ATP5PO RPS4Y1 PABPC4 MCCC1 TRRAP ABCB1 EFTUD2 RAB10 PARP1 TARS1 RAF1 RANGAP1 ZBTB33 EP400 NOC3L CASP3 TDRD1 ARAF KMT2D CCT5 NFXL1 SNRNP200 FTSJ3 | 3.75e-04 | 866 | 260 | 24 | int:RNF2 |
| Interaction | SYT3 interactions | 3.76e-04 | 27 | 260 | 4 | int:SYT3 | |
| Interaction | MEN1 interactions | UTP6 ERCC6 ACOT13 PABPC4 TRRAP EFTUD2 JAK1 UGDH DDX54 POLR1B ATXN10 RBM15 RANGAP1 EP400 CPSF6 UBR4 NOC3L SRBD1 PABPC1 ARHGAP5 KMT2D WDHD1 WDR82 NUP188 EIF2AK2 SNRNP200 FTSJ3 | 3.81e-04 | 1029 | 260 | 27 | int:MEN1 |
| Interaction | STAG1 interactions | 4.02e-04 | 104 | 260 | 7 | int:STAG1 | |
| Interaction | IFI16 interactions | UTP6 PABPC4 EFTUD2 JAK1 PARP1 AP2A2 SVIL DDX54 PKM POLR1B ATXN10 HEATR5B KIF11 RBM15 NOC3L SRBD1 PABPC1 CCT5 NUP188 EIF2AK2 FTSJ3 | 4.06e-04 | 714 | 260 | 21 | int:IFI16 |
| Interaction | KCNA3 interactions | PABPC4 RAB10 PARP1 SURF4 PKM TLN2 TARS1 KIF11 COL4A4 RAF1 RANGAP1 ZBTB33 DSP BZW2 ATG2B FNDC3A CCT2 ANKRD50 SHTN1 HELQ PABPC1 CCT5 TLN1 SNRNP200 | 4.07e-04 | 871 | 260 | 24 | int:KCNA3 |
| Interaction | BGLT3 interactions | 4.16e-04 | 75 | 260 | 6 | int:BGLT3 | |
| Interaction | RNF208 interactions | 4.16e-04 | 75 | 260 | 6 | int:RNF208 | |
| Interaction | HNRNPU interactions | ERCC6 HDAC4 INPPL1 PABPC4 ACTN4 EFTUD2 STXBP3 AP2A1 DDX54 MTCH1 RAB5A TARS1 MAGEL2 UBQLN2 CPSF6 NOC3L CASP3 ELP1 GAS7 FNDC3A SRBD1 PABPC1 ARAF DNAH1 WDHD1 SNRNP200 FTSJ3 | 4.17e-04 | 1035 | 260 | 27 | int:HNRNPU |
| Interaction | DSP interactions | PABPC4 TRRAP EFTUD2 JAK1 RAB5B RAF1 DSP PKP4 CASP4 CASP6 FNDC3A CCT2 PABPC1 ARAF WDR82 | 4.20e-04 | 423 | 260 | 15 | int:DSP |
| Interaction | RC3H2 interactions | PABPC4 CLASP2 AP2A1 AP2A2 DDX54 PKM POLR1B KIF11 RAF1 RBM15 DSP CPSF6 NOC3L CCT2 SRBD1 PABPC1 CCT5 PABPC3 WDR82 SNRNP200 | 4.37e-04 | 667 | 260 | 20 | int:RC3H2 |
| Interaction | ACLY interactions | INPPL1 EFTUD2 PKM ATXN10 RAF1 DSP UBR4 NEK7 CCT2 DDIAS PIM3 CCT5 LMBR1L | 4.37e-04 | 335 | 260 | 13 | int:ACLY |
| Interaction | HSP90AA1 interactions | MYH7 HDAC4 PABPC4 INSRR RABGAP1 ACTN1 ALDH1L1 EFTUD2 BLM JAK1 SVIL PKM DCLK2 SDR16C5 TARS1 NPHP1 ANKK1 RAF1 COL6A3 UBQLN2 UBR4 AHSA2P FNDC3A G2E3 CCT2 ARAF PIM3 TLN1 EIF2AK2 SNRNP200 EDRF1 | 4.41e-04 | 1263 | 260 | 31 | int:HSP90AA1 |
| Interaction | HECTD1 interactions | UTP6 MAGEB2 ERCC6 CENPE PABPC4 TRRAP EFTUD2 BLM DECR1 PARP1 AP2A1 DDX54 SCAPER POLR1B UTRN MTCH1 RPS4Y2 RBM15 NOC3L SRBD1 ARAF AARSD1 LMBR1L EIF2AK2 SNRNP200 FTSJ3 | 4.42e-04 | 984 | 260 | 26 | int:HECTD1 |
| Interaction | DDX39B interactions | HDAC4 PABPC4 ACTN4 ACTN1 EFTUD2 AP2A1 SVIL PKM RAF1 RBM15 DSP CPSF6 CCT2 PABPC1 CCT5 TMPRSS2 PRMT3 SNRNP200 | 4.62e-04 | 570 | 260 | 18 | int:DDX39B |
| Interaction | UBA2 interactions | USP34 ERCC6 PARP1 PKM ATXN10 UBQLN2 NEK7 FNDC3A SHTN1 ARPC5 TMPRSS2 | 4.69e-04 | 253 | 260 | 11 | int:UBA2 |
| Interaction | RUFY1 interactions | RPS4Y1 MCCC1 EFTUD2 MOGS PKM ATXN10 RAB5A RAB5C KIF11 RPS4Y2 RANGAP1 CCT2 CCT5 PRMT3 NUP188 SNRNP200 | 4.88e-04 | 476 | 260 | 16 | int:RUFY1 |
| GeneFamily | RAB, member RAS oncogene GTPases | RAB3C RAB10 RAB33A RAB5A RAB5B RAB6A RAB5C RAB6B RAB36 RAB21 | 7.86e-10 | 65 | 179 | 10 | 388 |
| GeneFamily | Actinins | 3.79e-06 | 4 | 179 | 3 | 1112 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 9.59e-06 | 50 | 179 | 6 | 1293 | |
| GeneFamily | A-kinase anchoring proteins|Myosins, class VII|Deafness associated genes|FERM domain containing | 9.75e-05 | 2 | 179 | 2 | 1102 | |
| GeneFamily | Caspases|Caspase recruitment domain containing | 2.54e-04 | 13 | 179 | 3 | 468 | |
| GeneFamily | Ubiquilin family | 9.56e-04 | 5 | 179 | 2 | 783 | |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 9.56e-04 | 5 | 179 | 2 | 1157 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | ATP5PO RABGAP1 USP9Y SUCLA2 COPS2 STXBP3 SCAPER RAB6A RAF1 UBQLN2 PKP4 NEK7 ELP1 ARHGAP5 TMX4 WDFY3 RAB21 EIF2AK2 | 4.21e-07 | 429 | 264 | 18 | M29 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | USP34 HDAC4 TRIO CENPE CLASP2 RABGAP1 TRRAP ME2 ITPR1 BLM FAT1 STXBP3 PLCB4 RAB6A KIF11 ARAP2 AGAP1 PMS1 PKP4 NEK7 FNDC3A MYOF WDHD1 PRMT3 WDFY3 RAB21 | 6.42e-07 | 856 | 264 | 26 | M4500 |
| Coexpression | MURARO_PANCREAS_DUCTAL_CELL | ATP5PO BAAT ATP10B ACTN4 ABCB1 EFTUD2 DECR1 RAB10 FAT1 MTUS1 SVIL UGP2 SEMA6A ALDH1A3 UTRN RAB5B RAB6A AGAP1 PKP4 SLC44A2 CASP4 CASP6 CCT2 MUC13 ARPC5 MYOF SH3PXD2B TSPAN8 TMPRSS2 SMS TANC1 TRIM47 | 2.05e-06 | 1276 | 264 | 32 | M39173 |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | BLM ERO1B DSP MFSD11 ATG2B PHTF2 ELP1 CCT5 TSHZ1 SNRNP200 SLC33A1 | 6.38e-06 | 200 | 264 | 11 | M6993 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | CNTNAP3B MYO7A PGM5 MTUS1 UGP2 STAB2 DSP BZW2 CASP4 GAS7 RAB6B ZFPM2 PPARGC1B SH3PXD2B TSHZ1 | 8.72e-06 | 382 | 264 | 15 | M45756 |
| Coexpression | ABDELMOHSEN_ELAVL4_TARGETS | 1.66e-05 | 16 | 264 | 4 | M2509 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | ACOT13 CLASP2 ACTN1 COPS2 TRRAP PARP1 FAT1 PKM UBQLN2 NEK7 CASP4 FNDC3A CCT2 ARPC5 MYOF TSPAN8 WDFY3 EIF2AK2 | 2.07e-05 | 568 | 264 | 18 | M4023 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | ABCA3 RIPOR2 MYO7A TBC1D32 MTUS1 GFOD1 AP1S2 SYT1 TLN2 DCLK2 PLCB4 TMCO3 AGAP1 PDE11A TRIM46 CACNA1C UBQLN2 BZW2 GRIK3 SHTN1 ZFPM2 PPARGC1B CNTNAP2 PAPPA CDH4 DCLK1 SEMA3E | 2.19e-05 | 1106 | 264 | 27 | M39071 |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | CENPN CLASP2 JAK1 ARAP2 PMS1 MFSD11 TSGA10 CASP3 RAB6B WDHD1 | 3.81e-05 | 200 | 264 | 10 | M8048 |
| Coexpression | GSE14350_TREG_VS_TEFF_DN | CENPN BAAT INSRR SYT1 ZDBF2 GRK1 RAB36 SH3PXD2B SOWAHB SMC1B | 3.81e-05 | 200 | 264 | 10 | M3418 |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN | 3.81e-05 | 200 | 264 | 10 | M7418 | |
| Coexpression | GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP | ACOT13 ACTN1 PARP1 ISYNA1 PHTF2 H6PD SLC44A1 PRKAG1 SMS TRIM47 | 3.81e-05 | 200 | 264 | 10 | M9080 |
| Coexpression | GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS | CNTNAP3B TRIO INPPL1 PABPC4 ACTN1 ITPR1 TLN2 PLCB4 PKP4 UBR4 AHSA2P RAB6B | 4.49e-05 | 292 | 264 | 12 | M43600 |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3 | BPIFB1 B3GALT5 ATP10B F5 PTPN3 MTUS1 UGP2 TTC13 ALDH1A3 AGAP1 DPY19L2 TCN1 MFSD11 PHTF2 MUC13 RAB6B ARHGAP5 SLC44A1 TMPRSS2 TSHZ1 | 5.24e-05 | 726 | 264 | 20 | M4210 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | ATP5PO CENPN CENPE BLM SLC35G1 PKM SYT1 DCLK2 KIF11 NPHP1 RBM15 RANGAP1 BZW2 CASP3 G2E3 HELQ WDHD1 TMX4 NUP188 | 6.71e-05 | 680 | 264 | 19 | MM456 |
| Coexpression | GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | 7.49e-05 | 175 | 264 | 9 | M6694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | TRIO CENPE CLASP2 RABGAP1 TRRAP BLM FAT1 RAB6A KIF11 AGAP1 PMS1 PKP4 NEK7 FNDC3A PRMT3 | 8.55e-05 | 466 | 264 | 15 | M13522 |
| Coexpression | RIGGINS_TAMOXIFEN_RESISTANCE_DN | 8.80e-05 | 221 | 264 | 10 | M15835 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | UTP6 CENPN CENPE COPS2 ME2 OSGEPL1 POLR1B SEMA6A TARS1 KIF11 PMS1 COL6A3 RBM15 BZW2 CPSF6 ZNF618 PKP4 NOC3L CASP6 CCT2 ZDBF2 THUMPD2 SLC44A1 WDHD1 TET1 CNTNAP2 PRMT3 EIF2AK2 EDRF1 RSKR | 9.17e-05 | 1407 | 264 | 30 | M14427 |
| Coexpression | CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN | 1.01e-04 | 106 | 264 | 7 | M17723 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | ATP5PO PABPC4 UBQLN4 COPS2 JAK1 PARP1 SVIL UGDH AP1S2 SYT1 SEMA6A DSP BZW2 ARPC5 MYOF SYTL5 | 1.15e-04 | 534 | 264 | 16 | M12522 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.35e-04 | 189 | 264 | 9 | M3112 | |
| Coexpression | MURARO_PANCREAS_ACINAR_CELL | CEL RPS4Y1 PABPC4 ATP10B ACTN4 MCCC1 MTUS1 FDX1 UGDH PNLIPRP1 TCN1 CASP4 CASP6 H6PD PABPC1 PIM3 PABPC3 TMPRSS2 TRIM47 | 1.74e-04 | 732 | 264 | 19 | M39174 |
| Coexpression | GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN | 1.84e-04 | 197 | 264 | 9 | M8136 | |
| Coexpression | GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP | LDHAL6A PABPC4 AGAP1 ATG2B PABPC1 FAAH2 PIM3 PABPC3 SNRNP200 | 1.84e-04 | 197 | 264 | 9 | M6081 |
| Coexpression | GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 1.91e-04 | 198 | 264 | 9 | M3324 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN | 1.91e-04 | 198 | 264 | 9 | M8274 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN | 1.91e-04 | 198 | 264 | 9 | M5010 | |
| Coexpression | GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN | 1.98e-04 | 199 | 264 | 9 | M8299 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 1.98e-04 | 199 | 264 | 9 | M7319 | |
| Coexpression | GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP | 1.98e-04 | 199 | 264 | 9 | M6992 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP | 2.00e-04 | 157 | 264 | 8 | M7731 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 2.06e-04 | 200 | 264 | 9 | M7150 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 2.06e-04 | 200 | 264 | 9 | M6254 | |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN | 2.06e-04 | 200 | 264 | 9 | M6249 | |
| Coexpression | ZHENG_RESPONSE_TO_ARSENITE_DN | 2.08e-04 | 12 | 264 | 3 | M1525 | |
| Coexpression | GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN | 2.18e-04 | 159 | 264 | 8 | M7734 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INHIBITORY_INTERNEURONS | 2.24e-04 | 30 | 264 | 4 | MM3663 | |
| Coexpression | FEVR_CTNNB1_TARGETS_UP | ABCA3 CEL TRIO MYO7A B3GALT5 ABCB1 AP2A2 SURF4 UGP2 RAB6A CRYBG2 PNLIPRP1 CASP3 CASP4 CLDN3 H6PD RAB21 SOWAHB | 2.34e-04 | 688 | 264 | 18 | M2342 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | CENPN CENPE BLM SLC35G1 FAT1 PKM KIF11 RANGAP1 CASP3 DDIAS WDHD1 SYTL5 EIF2AK2 | 2.41e-04 | 402 | 264 | 13 | MM454 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | PECR ERCC6 CENPN EFTUD2 BLM BPNT1 PARP1 PTPN3 SCAPER POLR1B DCLK2 KIF11 RPS4Y2 PMS1 LRRC34 DSP NOC3L PHTF2 G2E3 SHTN1 RAB6B DDIAS WDHD1 TET1 NFXL1 SMS PRMT3 NUP188 EDRF1 SMC1B | 9.28e-08 | 822 | 259 | 30 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_500 | BLM BPNT1 PTPN3 SCAPER POLR1B DCLK2 RPS4Y2 PMS1 LRRC34 NOC3L PHTF2 G2E3 SHTN1 TDRD1 RAB6B DDIAS TET1 SMC1B | 1.98e-06 | 396 | 259 | 18 | gudmap_dev gonad_e13.5_M_GermCell_Oct_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | ERCC6 ME2 EFTUD2 BLM TBC1D32 BPNT1 PTPN3 SCAPER POLR1B DCLK2 TTC13 RPS4Y2 PMS1 LRRC34 NOC3L PHTF2 G2E3 SHTN1 TDRD1 RAB6B DDIAS WDHD1 TET1 PRMT3 NUP188 SMC1B FTSJ3 | 2.41e-06 | 810 | 259 | 27 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | PECR EFTUD2 BLM BPNT1 PARP1 PTPN3 SCAPER POLR1B DCLK2 TTC13 KIF11 RPS4Y2 PMS1 LRRC34 NOC3L PHTF2 G2E3 SHTN1 RAB6B DDIAS WDHD1 TET1 PRMT3 NUP188 SMC1B FTSJ3 | 5.26e-06 | 795 | 259 | 26 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | EFTUD2 BPNT1 POLR1B DCLK2 RPS4Y2 PMS1 NOC3L PHTF2 G2E3 RAB6B DDIAS TET1 PRMT3 | 9.73e-06 | 243 | 259 | 13 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | PECR BLM BPNT1 PARP1 PTPN3 POLR1B DCLK2 KIF11 RPS4Y2 PMS1 NOC3L PHTF2 DDIAS WDHD1 TET1 PRMT3 NUP188 FTSJ3 | 1.69e-05 | 463 | 259 | 18 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ERCC6 CFAP54 ANKK1 CACNA1C LRRC34 TSGA10 ZDBF2 ZFPM2 DNAH1 RAB36 TMPRSS2 | 1.51e-08 | 185 | 264 | 11 | 05bc89a566b0db90ae06506e067190a4739a0974 |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ACTN4 ACTN1 FDX1 PKM UTRN COL4A4 DSP CLDN3 TSPAN8 TMPRSS2 SEMA3E | 2.88e-08 | 197 | 264 | 11 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ACTN4 ACTN1 FDX1 PKM UTRN COL4A4 DSP CLDN3 TSPAN8 TMPRSS2 SEMA3E | 2.88e-08 | 197 | 264 | 11 | b0fb5774525ba05f60c635d42f14bb8d79bff17c |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ACTN1 PGM5 ITPR1 FAT1 MTUS1 SYT1 COL6A3 ZFPM2 MYOF TSHZ1 CDH4 | 3.37e-08 | 200 | 264 | 11 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | CNTNAP3B RAB3C PGM5 ABCB1 CC2D2B GFOD1 SEMA6A PLCB4 PKP4 ZFPM2 | 1.95e-07 | 188 | 264 | 10 | d582b76fc2faac526c9bf97503041129e1a6a211 |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.59e-07 | 148 | 264 | 9 | 5e738522d4ad35e08bc4ff8c41b7bea38ec6ef95 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | ABCA3 UTRN COL4A4 PNLIPRP1 DSP SLC26A5 TSGA10 MYOF TMPRSS2 DCLK1 | 3.00e-07 | 197 | 264 | 10 | b94645d57efe8d9e032bffb8c89af1f425c6421e |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.25e-07 | 152 | 264 | 9 | 8ff5a178a8f3550d89a003c0858820aab3773386 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | CNTNAP3B CNTNAP3 ABCB1 CC2D2B MTUS1 GFOD1 SYT1 PLCB4 TDRD6 TRIM46 | 3.29e-07 | 199 | 264 | 10 | bd43a84e84d8acb8e1008b98a235cc5bd5f43586 |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.45e-07 | 200 | 264 | 10 | 87827041663013f5e7273168dc8709d69840e7ce | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.27e-07 | 157 | 264 | 9 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-06 | 179 | 264 | 9 | d3438fed0d85d5ed5afa8ff820c45143d77b6c0d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | CNTNAP3B CNTNAP3 PGM5 ABCB1 CC2D2B GFOD1 PLCB4 ZFPM2 TRAPPC3L | 1.34e-06 | 180 | 264 | 9 | 27e8bbee388e64dd79d70b160b76d45b1f398006 |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 182 | 264 | 9 | 9174fb0b7ed8f721a5c513e41fd80476a9f34332 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.47e-06 | 182 | 264 | 9 | 53c267ee327e116dbd89d5927ed3bdf78d25ee62 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 1.54e-06 | 183 | 264 | 9 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-06 | 183 | 264 | 9 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-06 | 186 | 264 | 9 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.84e-06 | 187 | 264 | 9 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.92e-06 | 188 | 264 | 9 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.92e-06 | 188 | 264 | 9 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.10e-06 | 190 | 264 | 9 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.28e-06 | 192 | 264 | 9 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.38e-06 | 193 | 264 | 9 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-4|World / Primary Cells by Cluster | 2.38e-06 | 193 | 264 | 9 | 2eb6e4cff4fe3ce564c1581f6f7df4834895aaa9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-06 | 193 | 264 | 9 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.06e-06 | 199 | 264 | 9 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-06 | 200 | 264 | 9 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.19e-06 | 200 | 264 | 9 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 200 | 264 | 9 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.58e-06 | 152 | 264 | 8 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | IIF-Lymphocyte-T_NK-ILC|IIF / Disease, Lineage and Cell Type | 4.99e-06 | 159 | 264 | 8 | 55e4f21548f480ca414c00cbff5ec3b13bafd271 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 6.85e-06 | 166 | 264 | 8 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.16e-06 | 167 | 264 | 8 | 1e144c03409df94ccd39760842590e8ea7487e29 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.27e-06 | 173 | 264 | 8 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.28e-06 | 124 | 264 | 7 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 9.67e-06 | 174 | 264 | 8 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.01e-05 | 175 | 264 | 8 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 1.01e-05 | 175 | 264 | 8 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 1.01e-05 | 175 | 264 | 8 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 175 | 264 | 8 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 1.09e-05 | 177 | 264 | 8 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.19e-05 | 179 | 264 | 8 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-05 | 180 | 264 | 8 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-05 | 180 | 264 | 8 | 7c7c4d64ff99d0710a7d19d8bc29fc9217394db1 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.24e-05 | 180 | 264 | 8 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.26e-05 | 130 | 264 | 7 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.39e-05 | 183 | 264 | 8 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 184 | 264 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.45e-05 | 184 | 264 | 8 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 184 | 264 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 184 | 264 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-05 | 185 | 264 | 8 | 29d7ddcb9a2e45f76cd5611f7c52b6df689effd3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.51e-05 | 185 | 264 | 8 | 780bdb63ef913a09930063286011c9108381d3a9 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.51e-05 | 185 | 264 | 8 | 274b8acccdfe434d14af4cb32fb615c06ec98435 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.51e-05 | 185 | 264 | 8 | b640d9ed6a1e6aa595053065bb992efc0402353e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 185 | 264 | 8 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 186 | 264 | 8 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-05 | 187 | 264 | 8 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.69e-05 | 188 | 264 | 8 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.69e-05 | 188 | 264 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 1.69e-05 | 188 | 264 | 8 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.69e-05 | 188 | 264 | 8 | 2db80767903703e7e0a1a37c598f7877a909ee94 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-05 | 189 | 264 | 8 | f0aaf2994d319a39877d2845eaab9f166adead4e | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 1.76e-05 | 189 | 264 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 190 | 264 | 8 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 190 | 264 | 8 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 190 | 264 | 8 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-05 | 190 | 264 | 8 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 190 | 264 | 8 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.83e-05 | 190 | 264 | 8 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 192 | 264 | 8 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 1.97e-05 | 192 | 264 | 8 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.97e-05 | 192 | 264 | 8 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | Control-Myeloid-MoAM4|Control / Disease group,lineage and cell class （2021.01.30） | 1.97e-05 | 192 | 264 | 8 | 1da7c303a2e36af4a9d8ec30a11380d9b1897922 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.97e-05 | 192 | 264 | 8 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 192 | 264 | 8 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 193 | 264 | 8 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-05 | 193 | 264 | 8 | 5dfa69a680a0859900141c40a446d217aaa747d3 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 193 | 264 | 8 | 536b277d90070c4571c592a3c6323b4bf4819f67 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.05e-05 | 193 | 264 | 8 | ebea35704ac5d21e947ae094313cf2a5205e7014 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-05 | 193 | 264 | 8 | 0499611c21d283321ef6dd24add154dea48da1b7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 193 | 264 | 8 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 193 | 264 | 8 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.05e-05 | 193 | 264 | 8 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.05e-05 | 193 | 264 | 8 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 2.05e-05 | 193 | 264 | 8 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.05e-05 | 193 | 264 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Control-Endothelial-Lymphatic|Control / Disease state, Lineage and Cell class | 2.05e-05 | 193 | 264 | 8 | 64d19be73e5432d491436a01da5de5c926b615a9 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte-|COVID-19_Severe / Disease condition and Cell class | 2.12e-05 | 194 | 264 | 8 | d70b9039fd2fef3e4be086513b94fb7e9bc1f670 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.12e-05 | 194 | 264 | 8 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-05 | 194 | 264 | 8 | e5990880961d2469759ce4b3b20ae93ace3ebd1f | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / Disease condition and Cell class | 2.12e-05 | 194 | 264 | 8 | 5151546812678ae85cb22224084d27b29e3c4724 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-05 | 195 | 264 | 8 | 23ab7e2a419377c05bab0e92a2457afbcd3d9e07 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 2.20e-05 | 195 | 264 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 196 | 264 | 8 | a52879a4c822c5e4be569f01f845a795e00c5f4b | |
| ToppCell | Control-Non-classical_Monocyte-|Control / Disease condition and Cell class | 2.29e-05 | 196 | 264 | 8 | b17ab094cdc7050c2997e24ed474779b5d6f6146 | |
| ToppCell | Control-Non-classical_Monocyte|Control / Disease condition and Cell class | 2.29e-05 | 196 | 264 | 8 | 404064ccfe2cb73df7a7f88aa65d86b97dcef9d4 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 196 | 264 | 8 | 7a4d502550e9e37dc42f2ff1be3c896afe365d7f | |
| Drug | AC1Q5QKX | 1.52e-06 | 3 | 263 | 3 | CID000164302 | |
| Drug | Myricetin [529-44-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | MAGEB2 RPS4Y1 RABGAP1 ALDH1L1 ITPR1 UTRN STAB2 TCN1 GAS7 MYOF NUP188 WDFY3 | 3.03e-06 | 195 | 263 | 12 | 4170_DN |
| Drug | N-acetylcysteamine | 3.46e-06 | 21 | 263 | 5 | CID000014484 | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | TRIO FDX1 SCAPER TLN2 CRYBG2 RANGAP1 TCN1 MPDU1 PHTF2 FNDC3A LMBR1L CNTNAP2 | 3.93e-06 | 200 | 263 | 12 | 6321_UP |
| Drug | Metipranolol | 6.04e-06 | 4 | 263 | 3 | ctd:D014290 | |
| Drug | JC-1 dye | 6.36e-06 | 85 | 263 | 8 | CID000003801 | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | TRRAP ITPR1 AP2A2 MTUS1 PKM TCN1 MPDU1 PHTF2 FNDC3A TLN1 DEDD | 1.47e-05 | 191 | 263 | 11 | 6721_DN |
| Drug | AC1LA2VQ | 1.50e-05 | 5 | 263 | 3 | CID000460718 | |
| Drug | 3-bromoacetylamino benzoic acid ethyl ester | 1.50e-05 | 5 | 263 | 3 | ctd:C416782 | |
| Drug | methylglyoxal | 1.51e-05 | 157 | 263 | 10 | CID000000880 | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | RABGAP1 DDX54 AP1S2 MOCS1 GAS7 TDRD1 CNGB3 TMPRSS2 WDFY3 DEDD EDRF1 | 1.96e-05 | 197 | 263 | 11 | 3572_DN |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; MCF7; HT_HG-U133A | USP34 HDAC4 CLASP2 AP2A2 SVIL STAB2 CASP3 RGS12 MYOF CNGB3 TMPRSS2 | 1.96e-05 | 197 | 263 | 11 | 3225_DN |
| Drug | Pantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; PC3; HT_HG-U133A | IL12B CEL F5 TAS2R10 TLN2 RAB5C TSGA10 NLRP1 GRIK3 RAB36 CDH4 | 2.05e-05 | 198 | 263 | 11 | 4189_UP |
| Drug | Lithocholic acid [434-13-9]; Up 200; 10.6uM; MCF7; HT_HG-U133A | ALDH1L1 SCAPER AP1S2 UTRN NPHP1 TSGA10 CASP4 ELP1 FNDC3A TDRD1 EDRF1 | 2.05e-05 | 198 | 263 | 11 | 3433_UP |
| Drug | LY294002 | IL12B MYH7 NT5C3A INPPL1 ACTN1 ABCB1 ITPR1 JAK1 PARP1 PTPN3 GSDME SYT1 RAB5A RAF1 OXER1 CASP3 CASP4 CASP6 NLRP1 FNDC3A HPDL ARAF CNGB3 | 2.14e-05 | 748 | 263 | 23 | CID000003973 |
| Drug | dunnione | 2.97e-05 | 6 | 263 | 3 | CID000262097 | |
| Drug | NDO 008 | 2.97e-05 | 6 | 263 | 3 | CID000131001 | |
| Disease | Psychotic Disorders | 3.07e-06 | 101 | 258 | 8 | C0033975 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 6.52e-06 | 5 | 258 | 3 | DOID:0111128 (implicated_via_orthology) | |
| Disease | hearing impairment | 2.53e-05 | 98 | 258 | 7 | C1384666 | |
| Disease | autosomal recessive intellectual developmental disorder (implicated_via_orthology) | 3.58e-05 | 8 | 258 | 3 | DOID:0060308 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.08e-05 | 152 | 258 | 8 | DOID:0060041 (implicated_via_orthology) | |
| Disease | dyslexia (implicated_via_orthology) | 7.62e-05 | 2 | 258 | 2 | DOID:4428 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ABCA3 ERCC6 HDAC4 ABCB1 PARP1 OTOGL HSD17B8 RAF1 PNLIPRP1 UBR4 AHSA2P TP53I3 ELP1 GRIK3 H6PD HELQ PABPC1 ARAF PPARGC1B KMT2D LIPE LBX1 CCT5 | 7.82e-05 | 1074 | 258 | 23 | C0006142 |
| Disease | Hypertrophic Cardiomyopathy | 1.42e-04 | 57 | 258 | 5 | C0007194 | |
| Disease | retinal degeneration (implicated_via_orthology) | 1.91e-04 | 33 | 258 | 4 | DOID:8466 (implicated_via_orthology) | |
| Disease | factor VIII measurement, venous thromboembolism | 2.15e-04 | 34 | 258 | 4 | EFO_0004286, EFO_0004630 | |
| Disease | amyotrophic lateral sclerosis type 15 (implicated_via_orthology) | 2.27e-04 | 3 | 258 | 2 | DOID:0060206 (implicated_via_orthology) | |
| Disease | 3-hydroxypropylmercapturic acid measurement | USP34 IGSF10 PKM MTCH1 PDE11A CPSF6 GAS7 ZFPM2 CNTNAP2 TMPRSS2 PAPPA | 2.97e-04 | 352 | 258 | 11 | EFO_0007014 |
| Disease | Hereditary hearing loss and deafness | 3.11e-04 | 146 | 258 | 7 | cv:C0236038 | |
| Disease | Bipolar Disorder | TRPM2 ME2 ITPR1 ANKK1 CACNA1C HTR1B LBX1 TPH2 TSPAN8 CNTNAP2 SMS DCLK1 TPH1 | 3.23e-04 | 477 | 258 | 13 | C0005586 |
| Disease | scoliosis (is_implicated_in) | 4.52e-04 | 4 | 258 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | growth/differentiation factor 11/8 measurement | 4.52e-04 | 4 | 258 | 2 | EFO_0021962 | |
| Disease | Adenocarcinoma of lung (disorder) | 4.86e-04 | 206 | 258 | 8 | C0152013 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 4.92e-04 | 42 | 258 | 4 | EFO_0004286, EFO_0004629 | |
| Disease | Nonsyndromic genetic hearing loss | 5.48e-04 | 76 | 258 | 5 | cv:C5680182 | |
| Disease | high grade glioma (implicated_via_orthology) | 5.89e-04 | 44 | 258 | 4 | DOID:3070 (implicated_via_orthology) | |
| Disease | Nonsyndromic Deafness | 7.33e-04 | 81 | 258 | 5 | C3711374 | |
| Disease | endometritis (biomarker_via_orthology) | 7.48e-04 | 5 | 258 | 2 | DOID:1002 (biomarker_via_orthology) | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 7.48e-04 | 5 | 258 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 7.48e-04 | 5 | 258 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 7.48e-04 | 5 | 258 | 2 | C1848640 | |
| Disease | response to bevacizumab, Proteinuria | 7.48e-04 | 5 | 258 | 2 | EFO_0005943, HP_0000093 | |
| Disease | Usher syndrome, type 1A | 7.48e-04 | 5 | 258 | 2 | C2931205 | |
| Disease | Usher syndrome type 1 | 7.48e-04 | 5 | 258 | 2 | cv:C1568247 | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 7.82e-04 | 21 | 258 | 3 | EFO_0004286, EFO_0004792 | |
| Disease | Ovarian Serous Adenocarcinoma | 1.03e-03 | 23 | 258 | 3 | C1335177 | |
| Disease | venous thromboembolism, tissue plasminogen activator measurement | 1.03e-03 | 23 | 258 | 3 | EFO_0004286, EFO_0004791 | |
| Disease | VACTERL association (implicated_via_orthology) | 1.12e-03 | 6 | 258 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | Usher Syndrome, Type I | 1.12e-03 | 6 | 258 | 2 | C1568247 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 1.12e-03 | 6 | 258 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | solute carrier family 22 member 16 measurement | 1.12e-03 | 6 | 258 | 2 | EFO_0802079 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.37e-03 | 93 | 258 | 5 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Vertigo | 1.44e-03 | 139 | 258 | 6 | HP_0002321 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.44e-03 | 139 | 258 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | Hereditary retinal dystrophy | 1.55e-03 | 7 | 258 | 2 | C0154860 | |
| Disease | anxiety, vitamin D measurement | 1.55e-03 | 7 | 258 | 2 | EFO_0004631, EFO_0005230 | |
| Disease | Usher syndrome | 1.55e-03 | 7 | 258 | 2 | cv:C0271097 | |
| Disease | Acute lymphocytic leukemia | 1.55e-03 | 7 | 258 | 2 | C0023449 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 1.78e-03 | 145 | 258 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Mental Depression | 1.87e-03 | 254 | 258 | 8 | C0011570 | |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 2.02e-03 | 61 | 258 | 4 | C1961102 | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 2.04e-03 | 29 | 258 | 3 | cv:C5779548 | |
| Disease | Congenital disorder of glycosylation type 1q | 2.06e-03 | 8 | 258 | 2 | C4317224 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 2.06e-03 | 8 | 258 | 2 | EFO_0801768 | |
| Disease | Sudden Cardiac Death | 2.06e-03 | 8 | 258 | 2 | C0085298 | |
| Disease | retinal disease (biomarker_via_orthology) | 2.06e-03 | 8 | 258 | 2 | DOID:5679 (biomarker_via_orthology) | |
| Disease | Schizophrenia | IL12B HDAC4 TRRAP ME2 ABCB1 ANKK1 CACNA1C CASP3 CASP4 GRIK3 RGS12 TET1 TPH2 TSPAN8 CNTNAP2 DCLK1 TPH1 | 2.11e-03 | 883 | 258 | 17 | C0036341 |
| Disease | factor XI measurement, venous thromboembolism | 2.25e-03 | 30 | 258 | 3 | EFO_0004286, EFO_0004694 | |
| Disease | glaucoma | 2.41e-03 | 154 | 258 | 6 | MONDO_0005041 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.65e-03 | 157 | 258 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | sensorineural hearing loss (is_implicated_in) | 2.97e-03 | 33 | 258 | 3 | DOID:10003 (is_implicated_in) | |
| Disease | tuberculosis | 3.03e-03 | 216 | 258 | 7 | MONDO_0018076 | |
| Disease | Nonorganic psychosis | 3.16e-03 | 69 | 258 | 4 | C0349204 | |
| Disease | anti-topoisomerase-I-antibody-positive systemic scleroderma | 3.27e-03 | 10 | 258 | 2 | EFO_0008537 | |
| Disease | Congenital Disorders of Glycosylation | 3.27e-03 | 10 | 258 | 2 | C0282577 | |
| Disease | Mood Disorders | 3.71e-03 | 168 | 258 | 6 | C0525045 | |
| Disease | Microphthalmos | 3.98e-03 | 11 | 258 | 2 | C0026010 | |
| Disease | glycerophosphorylcholine measurement | 3.98e-03 | 11 | 258 | 2 | EFO_0020018 | |
| Disease | Bardet-Biedl syndrome (implicated_via_orthology) | 3.98e-03 | 11 | 258 | 2 | DOID:1935 (implicated_via_orthology) | |
| Disease | Ashkenazi Jewish disorders | 3.98e-03 | 11 | 258 | 2 | cv:CN118946 | |
| Disease | Congenital disorder of glycosylation | 4.45e-03 | 38 | 258 | 3 | cv:C0282577 | |
| Disease | venous thromboembolism, factor VII measurement | 4.45e-03 | 38 | 258 | 3 | EFO_0004286, EFO_0004619 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 4.74e-03 | 12 | 258 | 2 | EFO_0801493 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 4.74e-03 | 12 | 258 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | Dental enamel hypoplasia | 4.74e-03 | 12 | 258 | 2 | EFO_1001304 | |
| Disease | granulins measurement | 4.74e-03 | 12 | 258 | 2 | EFO_0008141 | |
| Disease | QRS duration | 4.92e-03 | 298 | 258 | 8 | EFO_0005055 | |
| Disease | Kidney Neoplasm | 5.14e-03 | 40 | 258 | 3 | C0022665 | |
| Disease | Congenital small ears | 5.51e-03 | 41 | 258 | 3 | C0152423 | |
| Disease | Nephronophthisis | 5.57e-03 | 13 | 258 | 2 | C0687120 | |
| Disease | Major Depressive Disorder | 5.74e-03 | 243 | 258 | 7 | C1269683 | |
| Disease | Cardiomyopathies | 5.80e-03 | 130 | 258 | 5 | C0878544 | |
| Disease | FEV/FEC ratio | UTP6 USP34 ABCA3 HDAC4 PABPC4 CDH23 COPS2 ITPR1 MTUS1 FDX1 SVIL SCAPER ATXN10 ARAP2 COL6A3 DSP NOC3L PPARGC1B DNAH12 CNTNAP2 | 5.92e-03 | 1228 | 258 | 20 | EFO_0004713 |
| Disease | short-term memory | 6.11e-03 | 83 | 258 | 4 | EFO_0004335 | |
| Disease | Alveolitis, Fibrosing | 6.11e-03 | 83 | 258 | 4 | C4721507 | |
| Disease | severe acute respiratory syndrome, COVID-19 | MYO7A TRPM2 SUCLA2 TBPL2 COL6A3 CPSF6 HELQ ZFPM2 MALRD1 EIF2AK2 | 6.29e-03 | 447 | 258 | 10 | EFO_0000694, MONDO_0100096 |
| Disease | melanoma | 6.39e-03 | 248 | 258 | 7 | C0025202 | |
| Disease | Hamman-Rich syndrome | 6.47e-03 | 14 | 258 | 2 | C0085786 | |
| Disease | Pulmonary Fibrosis | 6.65e-03 | 85 | 258 | 4 | C0034069 | |
| Disease | Mammary Carcinoma, Human | ABCB1 PARP1 RAF1 ELP1 H6PD PABPC1 ARAF PPARGC1B KMT2D LBX1 CCT5 | 6.85e-03 | 525 | 258 | 11 | C4704874 |
| Disease | Mammary Neoplasms, Human | ABCB1 PARP1 RAF1 ELP1 H6PD PABPC1 ARAF PPARGC1B KMT2D LBX1 CCT5 | 6.85e-03 | 525 | 258 | 11 | C1257931 |
| Disease | Dystonia | 6.92e-03 | 86 | 258 | 4 | C0013421 | |
| Disease | Mammary Neoplasms | ABCB1 PARP1 RAF1 ELP1 H6PD PABPC1 ARAF PPARGC1B KMT2D LBX1 CCT5 | 7.04e-03 | 527 | 258 | 11 | C1458155 |
| Disease | Malignant neoplasm of kidney | 7.15e-03 | 45 | 258 | 3 | C0740457 | |
| Disease | electrocardiography | RIPOR2 PTPN3 SVIL TRIM63 TMCO3 RAF1 CACNA1C ZFPM2 PPARGC1B SH3PXD2B CNTNAP2 | 7.33e-03 | 530 | 258 | 11 | EFO_0004327 |
| Disease | pancreatic adenocarcinoma (is_implicated_in) | 7.42e-03 | 15 | 258 | 2 | DOID:4074 (is_implicated_in) | |
| Disease | response to olanzapine | 7.42e-03 | 15 | 258 | 2 | GO_0097333 | |
| Disease | Unipolar Depression | 8.03e-03 | 259 | 258 | 7 | C0041696 | |
| Disease | Breast Carcinoma | ABCB1 PARP1 RAF1 ELP1 H6PD PABPC1 ARAF PPARGC1B KMT2D LBX1 CCT5 | 8.16e-03 | 538 | 258 | 11 | C0678222 |
| Disease | Liver neoplasms | 8.35e-03 | 142 | 258 | 5 | C0023903 | |
| Disease | Malignant neoplasm of liver | 8.35e-03 | 142 | 258 | 5 | C0345904 | |
| Disease | Autistic Disorder | 8.36e-03 | 261 | 258 | 7 | C0004352 | |
| Disease | nevus count, cutaneous melanoma | 8.43e-03 | 91 | 258 | 4 | EFO_0000389, EFO_0004632 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 8.43e-03 | 16 | 258 | 2 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | cochlin measurement | 8.43e-03 | 16 | 258 | 2 | EFO_0801481 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 8.43e-03 | 16 | 258 | 2 | C1839071 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LADSGGIEKLVNITK | 956 | Q99569 | |
| GALLEKVAATLKTLV | 341 | A0A0G2JMD5 | |
| VADKLVTFGLAKNIT | 1111 | Q9BXT4 | |
| IKGGAAKLQIITDFD | 76 | Q9H0P0 | |
| KIGFSAADAVTGLKL | 321 | O00400 | |
| VLKQGKTLAFTSVDL | 106 | Q9NPJ3 | |
| SKGKFQELLVGIVVE | 36 | Q719I0 | |
| LVSGNSIEEKLLKNG | 2021 | Q96L91 | |
| SLVKEGIAASFAVKL | 176 | Q9Y6E2 | |
| SDILQALVLTGGEKK | 316 | P54619 | |
| KATKTLGIILGAFIV | 311 | P28222 | |
| LFIVGEGDKTINSKA | 321 | Q14032 | |
| GAVISAKIAQFIKSL | 1996 | Q96N23 | |
| AKFGKIVALNTGVSI | 1316 | Q9P2K9 | |
| SGTEFNAVKSLILGK | 1131 | Q9BZ76 | |
| ALDFIASKGVKLVSI | 96 | P12814 | |
| ELKVGIVGNLASGKS | 71 | Q9UPQ3 | |
| IGLINEKAADKLGST | 321 | Q8TDL5 | |
| LSSFQKVLELEGEKG | 51 | P61201 | |
| GGIALKKSGFINELI | 741 | Q96NH3 | |
| FINRDGETLTTKGKV | 71 | P10109 | |
| LKVLESLGKDFLTGV | 11 | P49662 | |
| EQGLADASLLKKVGF | 441 | Q9UBB4 | |
| LKGNTAILKVLVEAG | 701 | Q8NFD2 | |
| GLGTALKILFSEKEI | 406 | Q86YB8 | |
| TLETALGKVKLNLGG | 91 | O60443 | |
| LDFIASKGVKLVSIG | 116 | O43707 | |
| NKIAFTGSTEVGKLV | 251 | P47895 | |
| AEVTKAKLLGFGSAL | 901 | O95782 | |
| EKGNSVFILGAVKGI | 171 | P53420 | |
| LKTLNEAIEKSLGGA | 516 | Q8IYT2 | |
| KQKELGIASFGASIT | 816 | Q99758 | |
| SNGKKEVLSGFQVVL | 31 | Q9BTE6 | |
| VKGKQLKTFFLLGTT | 86 | Q9Y2C3 | |
| KNEQDFKSGLGITII | 616 | Q8WZ64 | |
| ILSKLLVDGLGNTKI | 391 | Q9ULJ7 | |
| ALKGVFITDSLKQAV | 271 | O75618 | |
| VNKKLGLLGDSVDIF | 36 | P19835 | |
| AGNKIIQLIEGKASA | 221 | O95861 | |
| IIFGTNGPVDLKKIT | 126 | P42574 | |
| FGKKALVLLGTSVLE | 1196 | Q6DHV5 | |
| TQAKALFKIDAITGV | 1356 | Q9H251 | |
| LGKTIQIIAFLAGLS | 536 | Q03468 | |
| TKEFLIAVGLKGATL | 1186 | Q96BY7 | |
| LVIDGKTLNAIFQGK | 996 | O94823 | |
| ELKTVLKSFLSQGQV | 156 | P48047 | |
| TKAKIIGFGSALLEE | 866 | O94973 | |
| GSIVLKVLISFKAND | 76 | O15511 | |
| TVKIGDFGLATVKSR | 481 | P04049 | |
| TIGIDFKIKTVELQG | 41 | P61026 | |
| IAKLAETLAKTQVAG | 6 | P46060 | |
| TLQASFLTKKLNIGG | 51 | Q9UL25 | |
| LLVEGSTGGKVAQLK | 816 | Q96T37 | |
| IFKIIVIGDSNVGKT | 36 | Q14088 | |
| ILINNAGIVTGKKFL | 121 | Q8N3Y7 | |
| FIFLVGTKKDLLSGA | 231 | O95755 | |
| FKLLIIGNSSVGKTS | 31 | Q96E17 | |
| TLKFTKGAGVNLILD | 201 | Q53FA7 | |
| FKLVLLGESAVGKSS | 21 | P20339 | |
| FKLVLLGESAVGKSS | 21 | P61020 | |
| QFKLVLLGESAVGKS | 21 | P51148 | |
| LVFLGEQSVGKTSLI | 16 | P20340 | |
| LVFLGEQSVGKTSLI | 16 | Q9NRW1 | |
| ILNETGKILLEKFGG | 151 | Q5T6V5 | |
| QVKIGDFGLTKAIET | 1016 | P23458 | |
| QLKKGLESGTVLIQF | 636 | P26045 | |
| KVFSATLGLVDIVKG | 551 | P09874 | |
| SGQTKVKSVLVDFLI | 306 | Q9NPH2 | |
| VKSVLVDFLIGSGLK | 311 | Q9NPH2 | |
| TKVFFKAGLLGLLEE | 761 | P12883 | |
| SGVGNIFIKNLDKSI | 96 | P11940 | |
| SILLTEQALAKAGKG | 91 | Q9GZZ8 | |
| LSLEVKKGQTLALVG | 1056 | P08183 | |
| DGTVTKKQGLRIIFS | 486 | Q15124 | |
| FLLGGEVQETSKKNV | 116 | P56377 | |
| ASILLNGKLKVESGQ | 1726 | Q8N7Z5 | |
| EGISVIFNVALGLLK | 751 | Q9Y3P9 | |
| GKFSIDSKTGAVFII | 3276 | Q14517 | |
| SGVGNVFIKNLDKSI | 96 | Q13310 | |
| VGLSFSLQLVGQLKK | 126 | Q9H4B0 | |
| EEIKKGLAAGITLNI | 81 | Q8IZ02 | |
| LVFKVATGELKNGFA | 781 | P56524 | |
| LLGGSDKQVSLFTKD | 296 | Q9HBG6 | |
| EILKKASEGLSVVFG | 151 | O15479 | |
| TNGLFGNTKKLITEV | 1146 | Q9UJ55 | |
| FEGKQGKILANTFIT | 116 | Q6ZNB6 | |
| LIKSGQLLGVKFIAE | 101 | Q86T24 | |
| ANDASKVLGSIAGKL | 446 | Q14643 | |
| ETGSVSALFQKIKGI | 626 | Q9ULD2 | |
| SNVGKLKTLSGALDI | 1096 | Q3B7T1 | |
| VKIGKLNLVDLAGSE | 256 | P52732 | |
| GLKVFSEAAQLIATK | 941 | Q8WW38 | |
| DAKIEIQTLTGLFKG | 131 | P55212 | |
| QTLKFTKELGKFTGL | 181 | Q8TDD1 | |
| SKSLKLGDFGLATIV | 526 | O15075 | |
| KSLKLGDFGLATVVE | 531 | Q8N568 | |
| TITLFLLGAAKGKEV | 6 | P54315 | |
| FLVEGAAAGKKTLVS | 241 | Q9HCR9 | |
| GKAIVKELLELGSNV | 31 | Q9BY49 | |
| NVFITATGVVKLGDL | 166 | Q8TDX7 | |
| KVVSLAELIGKDGTA | 376 | Q9C000 | |
| LGKELGLQAKELSAV | 311 | Q8IXT1 | |
| KTLFESLLLTQGGSK | 2791 | Q6ZR08 | |
| QLKILGLVAKGSFGT | 106 | Q96LW2 | |
| GSFGTVLKVLDCTQK | 116 | Q96LW2 | |
| QIKGLTGASGKVALL | 61 | Q6UX53 | |
| ISLQVKQKGADFLVT | 181 | P14618 | |
| TKSVVLQLADGQIFK | 566 | O95163 | |
| LGTIFGKSIARVEKV | 206 | P57789 | |
| GAVNDIKLLAVSGKN | 811 | Q13219 | |
| KGLELEVVAKTFLLG | 66 | Q6NUT2 | |
| ATNKFGAEEKSLIGL | 266 | O43934 | |
| SGKTLTIQVKEFGDA | 71 | P29460 | |
| AKEGVALTKGVAILN | 261 | A6NM76 | |
| QLKKGDALVVAQLAG | 526 | Q9NZB8 | |
| SGVGNIFVKNLDKSI | 96 | Q9H361 | |
| AEAIGKLKVQGEVSL | 401 | Q8TDS5 | |
| GDKGKFLLQVFTKSL | 316 | Q96IR7 | |
| FQLKEKGLSSGEQVL | 376 | Q13724 | |
| GVFGLASTAKLLVEV | 316 | Q9H158 | |
| FVSAKATGSIQILIK | 1601 | Q5VYJ5 | |
| GTAFVTLEIGKQLIK | 171 | Q16698 | |
| VGKTALVAKLAGLEV | 66 | Q9BU20 | |
| FESFKQGLKTLGVLE | 556 | Q7L622 | |
| TKDLGKALAIQTVVF | 1591 | Q9P2D7 | |
| LTVKIGDFGLATVKT | 441 | P10398 | |
| SVSLVGKGFLTQNKE | 256 | Q5TD97 | |
| GSLTINKVKLLDSGE | 2196 | Q6WRI0 | |
| LLVSSLDKVQAGKGS | 1391 | Q9P2D3 | |
| DIFLGSKSAKIQSGI | 1116 | P54132 | |
| VLNLVLGVLSGEFSK | 396 | Q13936 | |
| FALVGVGSEASSKKL | 126 | Q16630 | |
| LNIVLTAKGDEVKSG | 816 | Q8WTW3 | |
| IKDLKLGVSQQTIFS | 191 | P49917 | |
| FLVDTKQVKIGDFGL | 421 | P19525 | |
| AGAKKVLGVDQSEIL | 276 | O60678 | |
| QFVSGLLESGKSELK | 186 | P15813 | |
| SIDFGDKQSLTVGKV | 896 | Q9Y2H6 | |
| FLFQKVGKLAATAVG | 66 | Q8IVP5 | |
| DKVIAVNLKGTFLVT | 121 | Q92506 | |
| LGAKKFLILITDGVA | 726 | A8TX70 | |
| LDLGKFGEKVTQLTD | 851 | P15924 | |
| TKAQVLGAVKALGFA | 301 | P12111 | |
| SLFSEEGLKGEQVKL | 1076 | Q8N1P7 | |
| GEKLLQVKFSSCVGT | 51 | P55283 | |
| LETKFKSGLNGSILA | 271 | Q96H22 | |
| AIAKTDATVVALLKG | 151 | Q6GMR7 | |
| SVNGVASKAKLIILE | 601 | Q96RQ3 | |
| VALAGLLAAQKVISK | 286 | P23368 | |
| SLGLVETITGFLKIK | 371 | P14616 | |
| GTVAKGSFIITLVKI | 441 | Q8WWI5 | |
| ITDLVEGAKKANGVL | 201 | Q8IWA5 | |
| SLFLGKVIETGKIDQ | 1151 | Q9UHC6 | |
| LASKTFKGLEVSVLQ | 91 | P52954 | |
| TKGIQTLFLSLIGLK | 751 | Q8TDG4 | |
| KEASALGIQKIGGIF | 811 | Q13003 | |
| LGLAVELLDGQSKTK | 336 | Q15835 | |
| VSIILLGATGDLAKK | 26 | O95479 | |
| TNKQVFEGLTTGLLK | 1041 | Q9BY12 | |
| NGFKIKLIPGVSITE | 816 | P54277 | |
| SLFILGQVIKKLSDG | 261 | Q02224 | |
| SGTEFNAVKSLILGK | 1131 | Q96NU0 | |
| QQVGDLTFKKGEILL | 166 | O15259 | |
| SKQGSLTELGFLTKL | 196 | Q05469 | |
| KTTFGLKILFAIDGE | 586 | Q3ZCN5 | |
| QASLGVIKVISGFVK | 396 | Q8WTT2 | |
| VLSSIGKIFKEEGLL | 236 | Q9NZJ7 | |
| TAGKLTVVILEAKNL | 286 | P21579 | |
| NFILVVGEKEKISGT | 671 | P26639 | |
| AKNKLSTIGFILTGL | 36 | Q9NYW0 | |
| GGILEVFIKEAKNLT | 586 | Q8TDW5 | |
| FKKALLAVIGADSVT | 461 | Q9NYH9 | |
| GIVQKLSQADGSFLK | 2041 | P46939 | |
| KADGETILKGLQSIF | 16 | P52788 | |
| VSGVISDLLGFNLKL | 766 | Q8N3S3 | |
| KVGVGLESKLQESFQ | 606 | Q7Z4K8 | |
| TADKFLQLFGTKGVK | 436 | Q96LD4 | |
| SQVGDLKTLILGKAV | 391 | O60522 | |
| QKKISGLFTNIGLEE | 116 | A8MYB1 | |
| QVISGQFLSDKKIGT | 706 | Q15147 | |
| LKTAIGAVEKDVGLS | 71 | Q6UWJ1 | |
| ILGLSGAKIQKSDFQ | 146 | Q9BXR5 | |
| QSKKTLLALEGDGLV | 451 | O95425 | |
| GGTQKTFDKQIVLLF | 201 | P12259 | |
| IDLLTFLTGQKAVKV | 181 | Q9NXC2 | |
| SKLGSFGAVIQVVLI | 346 | Q6UX01 | |
| FIDSVGVKTLAGIVK | 651 | P58743 | |
| TVAGFELLLQKQLKG | 216 | O60861 | |
| GKKSFEQTLTVELCG | 586 | Q86YN6 | |
| EGLALGAVIASSKKA | 666 | Q8IY81 | |
| LDVTLGDLTKIGKSQ | 316 | O15357 | |
| VDELKGILGTLNKST | 446 | A0MZ66 | |
| TGKIINFIKFDTGNL | 166 | P22090 | |
| QIDLGTGKITSFIKF | 161 | Q8TD47 | |
| LTSFIGAIAIGDLVK | 26 | P78371 | |
| VGFGKTAIISKLVAL | 416 | Q9C0D5 | |
| AGLVQEISFGTTKDK | 356 | P48643 | |
| AIGFKTKLAALTLVV | 196 | O15260 | |
| TNIDKVNLFILGKDG | 591 | Q13017 | |
| FIGQSAVEKLILKSG | 766 | Q8IX21 | |
| KNGSKLIVFVIGGIT | 526 | O00186 | |
| IGFLLNVKDSKTLSV | 86 | Q13278 | |
| ALQDLVSGAKKAGIV | 646 | A6NEL2 | |
| QVFKILGAKSAEGLS | 61 | O75352 | |
| SDKKVLAILVNIFGG | 366 | Q9P2R7 | |
| VLTGKVENATLFGIF | 921 | Q8N5C6 | |
| GFISIKVTELKGLAT | 261 | Q9Y4F9 | |
| VIKFLLAGSKQATLG | 326 | Q8NFU7 | |
| LDFIASKGVKLVSIG | 111 | Q08043 | |
| VVTKAGLILFGNDDK | 271 | O75891 | |
| TAKAKITIVAGVLFL | 111 | O15551 | |
| KSVLVTLKAGSVFGE | 1016 | Q14028 | |
| DGTKVLVTLKAGSVF | 576 | Q9NQW8 | |
| GADLLGSVQAKVQKA | 746 | O75122 | |
| GGATFLLTAKQLIKS | 271 | Q969Q1 | |
| IFSLKNEVGGLIKAL | 21 | P17752 | |
| NEVGGLIKALKIFQE | 26 | P17752 | |
| SLFNTVTDKKIAILG | 321 | O60701 | |
| AFAKNGEILQISVGK | 76 | Q9H1E5 | |
| FGKNVSLKGTVIIIA | 466 | Q16851 | |
| AKGKVLILSSEFGEA | 731 | Q8NBP0 | |
| GKTSEVLNAAKVLLI | 391 | O15393 | |
| LGALSVVSGKEFLKL | 481 | Q5T7W0 | |
| VVSGKEFLKLAQTLV | 486 | Q5T7W0 | |
| SNQSILIKFKEGLSG | 1696 | Q8IZQ1 | |
| KFSNDGKLILISTNG | 201 | Q6UXN9 | |
| VAVKAGFSIKDILSG | 976 | O14924 | |
| KDKFQLILTIVGTIA | 416 | Q9H3R2 | |
| QKTVALDGTLFLKSG | 636 | Q8NDV3 | |
| ELKSAIKTQAGGLGI | 36 | Q76KD6 | |
| LGDLISATKAAAGKV | 2091 | Q9Y490 | |
| GISFQAGLKVEVIEK | 386 | A1X283 | |
| AFGDIVFTGLSQKVK | 126 | O94759 | |
| GTKIAAGSSDFLVKI | 106 | O75717 | |
| LFTIGGVQKEVFSLA | 556 | O75717 | |
| TVVFLGSEKGIILKF | 436 | Q9H2E6 | |
| SLINGQIKADEGSLK | 201 | P20061 | |
| VNSGAVILGKVVFSL | 331 | Q8N0Z6 | |
| VLSSLNIKLKEGEGL | 2011 | Q9HCK1 | |
| TIGKAFTAQEVGKVI | 216 | Q9BTF0 | |
| QGQLLIKTVKLAFSV | 806 | Q5SRE5 | |
| TDKGLKGFNVNELLV | 411 | Q8WWQ8 | |
| KLIDFGSGALLKDTV | 186 | Q86V86 | |
| ILSKVLGGSFADQKI | 1711 | O00507 | |
| VVFSLKNEVGGLVKA | 66 | Q8IWU9 | |
| AFSVAAVKGLGITIK | 236 | Q0D2K0 | |
| ISILGGTLNDLAKEK | 256 | Q9BZW7 | |
| ETSTDLKLLGKGNII | 1411 | O75643 | |
| KVSLVLSALQAGNKG | 1961 | Q9Y4G6 | |
| LGGQIFITKALQIEK | 296 | Q2M3R5 | |
| LFIGTDNGIVLKVIT | 451 | O15041 | |
| LKGDSVTEIGITFLK | 156 | Q5T215 | |
| ELKNTVKSLFGGVIT | 1996 | Q70CQ2 | |
| KSQTDQLVLIFAGKI | 66 | Q9UHD9 | |
| KALLGSVKDSIVQGF | 756 | Q15029 | |
| VLGILFTGTKDLLKS | 766 | Q5H8A4 | |
| LSEKIKQGDSSLVFG | 781 | Q9H9Y6 | |
| SKEKLQGFAAVLAIG | 1191 | Q5T4S7 | |
| QLVLIFAGKILKDGD | 51 | Q9NRR5 | |
| KDTQGLLAVGEALIK | 286 | A8MYJ7 | |
| VKKLVSTFGVGLENV | 3371 | Q9Y4A5 | |
| KGGLDILKSLENTVS | 546 | Q6ZSZ6 | |
| LLLQVATGILGAVFK | 96 | P19075 | |
| IFVSGKVVLTGAKER | 341 | Q6SJ96 | |
| GKIVAQGKLLLQDTF | 2156 | O75962 | |
| TDGIGNESVKILAKL | 231 | Q8NBT3 | |
| VGLSGLSSKAAKDVL | 396 | Q14003 | |
| IDSKLAGLEQKLQGT | 4491 | O14686 | |
| GENGITDLIKVKLTL | 296 | Q6ZMR3 | |
| GAGKTESTKLILQFL | 161 | Q13402 | |
| GAGKTETTKLILQFL | 161 | Q6PIF6 | |
| GIIVKDFETIGQNKL | 66 | Q9NZM1 |